Table of Content
Table of Contents
5 Volumes:
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2
COVID-19 Pandemic Mitigation products Market – 2020-2024: Volume 3
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 5
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 1
1 Market Definition………………………………….. 9
1.1 Introduction…………………………………….. 9
1.2 Scenario A: Assumptions………………….. 9
1.3 Scenario B: Assumptions………………….. 9
2 Executive Summary…………………………….. 11
2.1 Key Findings…………………………………. 11
2.2 COVID-19 Mitigation Funding (January – May 2020)……………………………………. 27
2.3 Key Conclusions……………………………. 30
2.4 COVID-19 Pandemic Mitigation Products Market Research Vectors………………… 45
2.5 COVID-19 Pandemic Mitigation R&D Challenges……………………………………. 45
2.6 Global COVID-19 Pandemic Mitigation Market – 2020-2024………………………… 46
2.6.1 Products & Services Groups Markets……………………………………………… 46
2.6.2 Products & Services Markets……… 50
2.6.3 Vertical Markets……………………….. 54
2.6.4 Revenue Source Markets…………… 55
2.6.5 Regional Markets……………………… 55
2.6.6 National Markets………………………. 56
3 The SARS-CoV-2 2019 Pandemic………….. 58
3.1 COVID-19 Basics…………………………… 58
3.2 COVID-19 Infection Rate…………………. 61
3.3 Social Distancing……………………………. 62
3.4 The Effect of Quarantine…………………. 64
3.5 Comparison of SARS-CoV-2 and Common Cold and Flu Viruses………….. 65
3.6 The SARS-CoV-2 Genome Information 66
3.7 Active Infection Testing…………………… 67
3.7.1 Nucleic Acid Detection………………. 67
3.7.2 Antigen Detection…………………….. 69
3.7.3 Other Technologies…………………… 69
3.8 Serology Testing……………………………. 70
4 Market Drivers…………………………………….. 73
5 Market Inhibitors…………………………………. 74
6 COVID-19 Pandemic Mitigation Products Market SWOT Analysis………………………… 75
6.1 Strengths……………………………………… 75
6.2 Weaknesses…………………………………. 76
6.3 Opportunities………………………………… 77
6.4 Threats………………………………………… 79
7 Business Opportunities & Challenges…… 81
8 COVID-19 Pandemic Mitigation Industry… 83
8.1 The COVID-19 Pandemic Mitigation Products Value Chain…………………….. 83
8.2 COVID-19 Pandemic Mitigation Products Industry Primary Activities……………….. 84
8.3 COVID-19 Pandemic Mitigation Products industry Support Activities……………….. 84
9 COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution…. 86
GLOBAL MARKET……………………………………… 87
10 Global COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 87
10.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets – 2020-2024……………………………………. 87
10.1.1 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario A………. 87
10.1.1.1 Market Size…………………………… 87
10.1.1.2 Market Dynamics…………………… 89
10.1.1.3 Market Share………………………… 89
10.1.2 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenario B………. 90
10.1.2.1 Market Size…………………………… 90
10.1.2.2 Market Dynamics…………………… 91
10.1.2.3 Market Share………………………… 92
10.1.3 Global COVID-19 Pandemic Mitigation Market: Scenarios Comparison…………………………….. 92
10.2 Global COVID-19 Pandemic Mitigation Products & Services Markets – 2020-2024…………………………………………………… 93
10.2.1 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario A………………….. 94
10.2.1.1 Market Size…………………………… 94
10.2.1.2 Market Dynamics…………………… 96
10.2.2 Global COVID-19 Pandemic Mitigation Products & Services Markets: Scenario B………………….. 98
10.2.2.1 Market Size…………………………… 98
10.2.2.2 Market Dynamics………………….. 101
10.2.3 Global COVID-19 Pandemic Mitigation Products & Services Groups Markets: Scenarios Comparison…………………………… 103
10.3 Global Vertical COVID-19 Pandemic Mitigation Markets – 2020-2024………. 104
10.3.1 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario A…………………………………………. 104
10.3.1.1 Market Size…………………………. 104
10.3.1.2 Market Dynamics………………….. 105
10.3.1.3 Market Share……………………….. 105
10.3.2 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenario B…………………………………………. 106
10.3.2.1 Market Size…………………………. 106
10.3.2.2 Market Dynamics………………….. 106
10.3.2.3 Market Share……………………….. 107
10.3.3 Global COVID-19 Pandemic Mitigation Vertical Markets: Scenarios Comparison…………………………… 107
10.4 Global COVID-19 Pandemic Mitigation Products & Services Market by Revenue Source – 2020-2024……………………… 108
10.4.1 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario A………………….. 108
10.4.2 Global COVID-19 Pandemic Mitigation Products & Services Market: Scenario B………………….. 109
10.4.3 Global COVID-19 Pandemic Mitigation Revenue Sources: Scenarios Comparison…………….. 111
10.5 Regional COVID-19 Pandemic Mitigation Markets – 2020-2024……………………. 112
10.5.1 Regional COVID-19 Pandemic Mitigation Market: Scenario A……. 112
10.5.1.1 Market Size…………………………. 112
10.5.1.2 Market Dynamics………………….. 112
10.5.1.3 Market Share……………………….. 113
10.5.2 Regional COVID-19 Pandemic Mitigation Market: Scenario B……. 113
10.5.2.1 Market Size…………………………. 113
10.5.2.2 Market Dynamics………………….. 114
10.5.2.3 Market Share……………………….. 114
10.5.3 Regional COVID-19 Pandemic Mitigation Market: Scenarios Comparison…………………………… 115
10.6 National COVID-19 Pandemic Mitigation Markets – 2020-2024……………………. 116
10.6.1 National COVID-19 Pandemic Mitigation Market: Scenario A……. 116
10.6.1.1 Market Size…………………………. 116
10.6.1.2 Market Dynamics………………….. 118
10.6.1.3 Market Shares……………………… 118
10.6.2 National COVID-19 Pandemic Mitigation Market: Scenario B……. 119
10.6.2.1 Market Size…………………………. 119
10.6.2.2 Market Dynamics………………….. 121
10.6.2.3 Market Share……………………….. 122
10.6.3 COVID-19 National Markets: Scenarios Comparison…………….. 122
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 2
PRODUCT/SERVICE MARKETS……………………. 32
1 COVID-19 Vaccines Market – 2020-2024… 32
1.1 COVID-19 Vaccines Market Background…………………………………………………… 32
1.1.1 Introduction……………………………… 32
1.1.2 Global COVID-19 Vaccine Development Funding……………….. 38
1.1.3 Vaccines Prices……………………….. 48
1.1.4 COVID-19 Vaccines Market: Conclusions…………………………….. 50
1.1.5 COVID-19 Vaccines:Business Opportunities…………………………… 53
1.1.6 COVID-19 Vaccines: Competitive Analysis: : Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………………… 54
1.1.7 Present and Potential Vendors……. 55
1.2 Global COVID-19 Pandemic Mitigation: Vaccines Market – 2020-2024………….. 58
1.2.1 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A………………………………. 58
1.2.2 Vaccines COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B………………………………. 59
2 COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024……………………………… 60
2.1 COVID-19 Post-Infection Therapies Drugs Market Background………………………… 60
2.1.1 Introduction……………………………… 60
2.1.2 Computer Aided COVID-19 Drug Research………………………………… 66
2.1.3 Adaptive Designs For COVID-19 Clinical Trials…………………………… 67
2.1.4 COVID-19 Therapeutic Drugs Market: Conclusions…………………. 67
2.1.5 COVID-19 Therapeutic Drug :Business Opportunities…………….. 69
2.1.6 COVID-19 Post-Infection Therapeutic Drug: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………… 70
2.1.7 Present and Potential Vendors……. 71
2.2 Global COVID-19 Post-Infection Therapeutic Drugs Market – 2020-2024 74
2.2.1 COVID-19 Post Infection Therapeutic Drugs Market – 2020-2024: Scenario A…………………………………………… 74
2.2.2 Therapeutic Drugs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………… 75
3 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024.. 76
3.1 Other COVID-19 Pharma Industry Products Market Background…………… 76
3.1.1 Introduction and Findings…………… 76
3.1.2 Other COVID-19 Pharma Industry Products Market: Conclusions……. 78
3.1.3 Other COVID-19 Pharma Industry Products: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution…….. 79
3.2 Global COVID-19 Pandemic Mitigation: Other Pharma Industry Products Market – 2020-2024……………………………………. 80
3.2.1 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…. 80
3.2.2 Other Pharma Industry Products COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…. 80
4 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024.. 82
4.1 COVID-19 PCR Instrumentation & Software Market Background…………… 82
4.1.1 Introduction……………………………… 82
4.1.2 PCR Technologies & Procedures… 84
4.1.3 PCR Advantages……………………… 88
4.1.4 PCR Limitations……………………….. 88
4.1.5 PCR Based Coronavirus Diagnostics Used and Developed During January – April 2020……………………………. 90
4.1.6 Efforts to Develop and Disseminate a Test for COVID-19……………………. 91
4.1.7 PCR Purchasing Considerations…. 92
4.1.8 Costs of PCR Testing………………… 93
4.1.9 PCR Instrumentation & Software Market: Conclusions…………………. 93
4.1.10 PCR Instrumentation & Software: Business Opportunities……………… 94
4.1.11 PCR Instrumentation & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………….. 95
4.1.12 Key Vendors……………………………. 96
4.2 Global COVID-19 Pandemic Mitigation: PCR Instrumentation & Software Market – 2020-2024……………………………………. 96
4.2.1 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…. 97
4.2.2 PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…. 97
5 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024.. 98
5.1 COVID-19 Robotic PCR Systems & Software Market Background…………… 98
5.1.1 Introduction and Findings…………… 98
5.1.2 Pooling PCR Method Testing Over 60 Samples Simultaneously……… 102
5.1.3 Robotic PCR Systems & Software Market: Conclusions………………… 102
5.1.4 Robotic PCR Systems & Software: Business Opportunities……………. 103
5.1.5 Robotic PCR Systems & Software: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………… 104
5.2 Global COVID-19 Pandemic Mitigation: Robotic PCR Systems & Software Market – 2020-2024………………………………… 105
5.2.1 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 105
5.2.2 Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 106
6 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024 107
6.1 COVID-19 PCR Reagents & Consumables Market Background…… 107
6.1.1 Introduction……………………………. 107
6.1.2 PCR Reagents & Consumables Market: Conclusions………………… 108
6.1.3 PCR Reagents & Consumables: Business Opportunities……………. 109
6.1.4 PCR Reagents & Consumables: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………… 110
6.2 1.2 Global COVID-19 Pandemic Mitigation: PCR Reagents & Consumables Market – 2020-2024….. 111
6.2.1 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 111
6.2.2 PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 112
7 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 113
7.1 COVID-19 Nose & Mouth Swabs Market Background…………………………………. 113
7.1.1 Introduction and Findings…………. 113
7.1.2 Nose & Mouth Swabs: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………………. 116
7.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Market – 2020-2024………………………………………….. 117
7.2.1 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 117
7.2.2 Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 117
8 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024 119
8.1 COVID-19 Self-collection PCR Test Kits Market Background………………………. 119
8.1.1 Saliva Tests…………………………… 120
8.2 COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Market – 2020-2024………………………………………….. 122
8.2.1 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 123
8.2.2 Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 123
9 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 124
9.1 COVID-19 Serologic Test Kits Market Background…………………………………. 124
9.1.1 Introduction and Findings…………. 124
9.1.2 FDA Statement Related to the Status of Serological (Antibody) Tests….. 130
9.1.3 Coronavirus Antibody Test Kits….. 131
9.1.4 Serologic Test Kits Market: Conclusions…………………………… 135
9.1.5 Serologic Test Kits: Business Opportunities…………………………. 137
9.1.6 Serologic Test Kits: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………………. 138
9.1.7 Key Vendors………………………….. 139
9.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Market – 2020-2024…………………………………………………. 139
9.2.1 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 139
9.2.2 Serologic Test Kits COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 140
10 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 141
10.1 COVID-19 Standoff Thermometry Market Background…………………………………. 141
10.1.1 Introduction and Findings…………. 141
10.1.2 Standoff Thermometry Market: Conclusions…………………………… 144
10.1.3 Standoff Thermometry: Business Opportunities…………………………. 145
10.1.4 Key Vendors………………………….. 145
10.2 Global COVID-19 Pandemic Mitigation: Standoff Thermometry Market – 2020-2024………………………………………….. 145
10.2.1 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 146
10.2.2 Standoff Thermometry COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 146
11 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 147
11.1 COVID-19 X-Ray Procedures Market Background…………………………………. 147
11.1.1 Introduction and Findings…………. 147
11.1.2 X-Ray Procedures Market: Conclusions…………………………… 152
11.1.3 Key Vendors………………………….. 153
11.2 Global COVID-19 Pandemic Mitigation: X-Ray Procedures Market – 2020-2024. 153
11.2.1 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 154
11.2.2 X-Ray Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 154
12 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 155
12.1 COVID-19 CT Procedures Market Background…………………………………. 155
12.1.1 Introduction and Findings…………. 155
12.1.2 CT Procedures Market: Conclusions……………………………………………. 158
12.1.3 CT Procedures: Business Opportunities…………………………. 159
12.1.4 Key Vendors………………………….. 159
12.2 Global COVID-19 Pandemic Mitigation: CT Procedures Market – 2020-2024… 159
12.2.1 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 160
12.2.2 CT Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 160
13 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 162
13.1 COVID-19 Ultrasound Procedures Market Background…………………………………. 162
13.1.1 Introduction and Findings…………. 162
13.1.2 FDA Approved “ EMT & Field” Smartphone-Tablet Based Coronavirus Chest Ultrasound…… 164
13.1.3 COVID-19 Chest Ultrasound Diagnostics……………………………. 164
13.1.4 Ultrasound Procedures Market: Conclusions…………………………… 165
13.1.5 Ultrasound Procedures: Business Opportunities…………………………. 166
13.1.6 Key Vendors………………………….. 166
13.2 Global COVID-19 Pandemic Mitigation: Ultrasound Procedures Market – 2020-2024………………………………………….. 167
13.2.1 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 167
13.2.2 Ultrasound Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 167
14 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 169
14.1 COVID-19 FDG-PET/CT Procedures & Wastewater Testing Market Background…………………………………………………. 169
14.1.1 Introduction and Findings…………. 169
14.1.2 FDG-PET/CT Procedures…………. 170
14.1.3 COVID-19 Wastewater Testing….. 171
14.1.4 FDG-PET/CT Procedures & Wastewater Testing Market: Conclusions…………………………… 173
14.1.5 FDG-PET/CT Procedures & Wastewater Testing: Business Opportunities…………………………. 173
14.1.6 Key Vendors………………………….. 173
14.2 Global COVID-19 Pandemic Mitigation: FDG-PET/CT Procedures & Wastewater Testing Market – 2020-2024…………… 173
14.2.1 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 174
14.2.2 FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 174
15 PACS & Teleradiology COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 176
15.1 PACS & Teleradiology Market Background…………………………………. 176
15.1.1 Introduction and Findings…………. 176
15.1.2 The FDA PACS & Teleradiography COVID-19 Pandemic Policy………. 180
15.1.3 PACS & Teleradiology Market: Conclusions…………………………… 181
15.1.4 PACS & Teleradiology: Business Opportunities…………………………. 181
15.1.5 Key Vendors………………………….. 182
15.2 Global COVID-19 Pandemic Mitigation: PACS & TeleradiologyMarket – 2020-2024………………………………………….. 182
15.2.1 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 183
15.2.2 PACS & TeleradiologyCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 183
16 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 184
16.1 Pandemic PPE Gowns Market Background…………………………………. 184
16.1.1 Introduction and Findings…………. 184
16.1.2 PPE Gowns Market: Conclusions 190
16.1.3 PPE Gowns: Business Opportunities……………………………………………. 190
16.2 Global COVID-19 Pandemic Mitigation: PPE Gowns Market – 2020-2024…….. 191
16.2.1 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 191
16.2.2 PPE Gowns COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 192
17 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 193
17.1 COVID-19 Gloves Market Background 193
17.1.1 Introduction and Findings…………. 193
17.1.2 Gloves Market: Conclusions…….. 194
17.1.3 Gloves: Business Opportunities…. 194
17.2 Global COVID-19 Pandemic Mitigation: Gloves Market – 2020-2024…………… 195
17.2.1 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 195
17.2.2 Gloves COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 196
18 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 197
18.1 Medical Face Masks Market Background…………………………………………………. 197
18.1.1 Introduction and Findings…………. 197
18.1.2 N95 Masks Vs. Surgical Mask…… 198
18.1.3 Face Masks Precautions………….. 203
18.1.4 Face Masks Market: Conclusions 204
18.1.5 Face Masks: Business Opportunities……………………………………………. 204
18.1.6 Key Vendors………………………….. 204
18.2 Global COVID-19 Pandemic Mitigation: Face Masks Market – 2020-2024…….. 205
18.2.1 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 206
18.2.2 Face Masks COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 206
19 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 207
19.1 Medical Face Shields Market Background…………………………………………………. 207
19.1.1 Introduction and Findings…………. 207
19.1.2 Face Shields Standards…………… 209
19.2 Global COVID-19 Pandemic Mitigation: Medical Face Shields Market – 2020-2024…………………………………………………. 210
19.2.1 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 210
19.2.2 Medical Face Shields COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 211
20 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 212
20.1 Pandemic Eye Protection Market Background…………………………………. 212
20.1.1 Introduction and Findings…………. 212
20.1.2 Key Vendors………………………….. 213
20.2 Global COVID-19 Pandemic Mitigation: Eye Protection Market – 2020-2024…. 214
20.2.1 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 214
20.2.2 Eye Protection COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 215
21 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 216
21.1 Global COVID-19 Pandemic Mitigation: PPE Sterilization: Systems & Consumables Market – 2020-2024….. 216
21.1.1 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 216
21.1.2 PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 217
22 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024 218
22.1 Hand & Surface Sanitizers Market Background…………………………………. 218
22.2 Global COVID-19 Pandemic Mitigation: Hand & Surface Sanitizers Market – 2020-2024………………………………………….. 221
22.2.1 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 221
22.2.2 Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 222
23 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 223
23.1 Decontamination Market Background. 223
23.1.1 Introduction……………………………. 223
23.1.2 Definitions……………………………… 224
23.1.3 Timing and Location Of Cleaning And Disinfection Of Surfaces…………… 224
23.1.4 Hard (Non-porous) Surfaces……… 225
23.1.5 Soft (Porous) Surfaces…………….. 225
23.1.6 Electronics…………………………….. 225
23.1.7 Linens, Clothing, and Other Items That Go in the Laundry…………….. 226
23.1.8 Risk of Exposure…………………….. 226
23.1.9 Considerations for Employers……. 227
23.1.10 Decontamination Market: Conclusions…………………………… 227
23.2 Global COVID-19 Pandemic Mitigation: Decontamination Market – 2020-2024 228
23.2.1 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 229
23.2.2 Decontamination COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 229
24 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024 231
24.1 Global COVID-19 Pandemic Mitigation: Other Personal Protection Gear Market – 2020-2024………………………………….. 231
24.1.1 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 231
24.1.2 Other Personal Protection Gear COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 232
25 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024 233
25.1 Pandemic AI, Big Data & Deep Learning Market Background………………………. 233
25.1.1 Introduction and Findings…………. 233
25.1.2 AI Based Early Warnings and Alerts……………………………………………. 235
25.1.3 Tracking and Prediction……………. 235
25.1.4 Data Dashboards……………………. 237
25.1.5 Diagnosis and Prognosis………….. 237
25.1.6 COVID-19 Treatments Optimization……………………………………………. 238
25.1.7 COVID-19 Pandemic Social Control……………………………………………. 239
25.1.8 Pandemic Outbreak Forecasting.. 240
25.1.9 AI, Big-Data and Deep Learning Assisted CT Imaging……………….. 242
25.1.10 AI, Big-Data and Deep-Learning Assisted COVID-19 Treatment….. 243
25.1.11 COVID-19: AI Assisted X-rays Imaging………………………………… 244
25.1.12 COVID-19 AI, Big Data & Deep Learning……………………………….. 244
25.1.13 AI Assisted Pandemic Symptoms Analysis………………………………… 246
25.1.14 AI, Big Data & Deep Learning Market: Conclusions…………………………… 247
25.1.15 AI, Big Data & Deep Learning: Business Opportunities……………. 248
25.1.16 Key Vendors………………………….. 248
25.2 Global COVID-19 Pandemic Mitigation: AI, Big Data & Deep Learning Market – 2020-2024………………………………….. 250
25.2.1 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 250
25.2.2 AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 250
26 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 252
26.1 Pandemic Homecare IT Market Background…………………………………. 252
26.1.1 Introduction and Findings…………. 252
26.1.2 Homecare IT Market: Conclusions……………………………………………. 253
26.1.3 Homecare IT: Business Opportunities……………………………………………. 254
26.1.4 Key Vendors………………………….. 254
26.2 Global COVID-19 Pandemic Mitigation: Homecare IT Market – 2020-2024…… 255
26.2.1 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 255
26.2.2 Homecare IT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 255
27 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 257
27.1 Pandemic Geo-Surveillance Systems & Services Market Background………….. 257
27.1.1 Introduction and Findings…………. 257
27.1.2 MIT “Private Kit”……………………… 263
27.1.3 The UK NHS COVID-19 App…….. 265
27.1.4 Companies Making Cell Location Tracking Technology……………….. 266
27.2 Global COVID-19 Pandemic Mitigation: Geo-Surveillance Systems & Services Market – 2020-2024……………………… 270
27.2.1 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 271
27.2.2 Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 271
28 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 272
28.1 Pandemic E-Health Market Background…………………………………………………. 272
28.1.1 Introduction and Findings…………. 272
28.1.2 E-Health Market: Conclusions….. 274
28.1.3 E-Health: Business Opportunities. 275
28.1.4 Key Vendors………………………….. 275
28.2 Global COVID-19 Pandemic Mitigation: E-Health Market – 2020-2024……………. 275
28.2.1 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 276
28.2.2 E-Health COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 276
29 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024 277
29.1 Pandemic Blockchain Technologies Market Background………………………. 277
29.1.1 Introduction and Findings…………. 277
29.1.2 Blockchain in Healthcare………….. 279
29.1.3 Blockchain Applications……………. 279
29.1.4 Blockchain Technologies Market: Conclusions…………………………… 282
29.1.5 Blockchain Technologies: Business Opportunities…………………………. 283
29.1.6 Key Vendors………………………….. 283
29.2 Global COVID-19 Pandemic Mitigation: Blockchain Technologies Market – 2020-2024………………………………………….. 284
29.2.1 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 284
29.2.2 Blockchain Technologies COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 285
30 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 286
30.1 Other Pandemics ICT Market Background…………………………………………………. 286
30.1.1 Introduction and Findings…………. 286
30.1.2 Other ICT Market: Conclusions…. 288
30.1.3 Other ICT: Business Opportunities 289
30.1.4 Vendors………………………………… 289
30.2 Global COVID-19 Pandemic Mitigation: Other ICT Market – 2020-2024……….. 290
30.2.1 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 291
30.2.2 Other ICT COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 291
31 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024 293
31.1 Non-Invasive Ventilators Market Background…………………………………. 293
31.1.1 Introduction and Findings…………. 293
31.1.2 The U.S. HHS Procurement Contracts On Non-Invasive Ventilators With Ten Vendors………………………….. 299
31.1.3 Helmet-Based Non-invasive Ventilators…………………………….. 299
31.1.4 Non-invasive Ventilators Market: Conclusions…………………………… 300
31.1.5 Business Opportunities……………. 301
31.1.6 Non-invasive Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution……………………………. 302
31.1.7 Key Vendors………………………….. 303
31.2 Global COVID-19 Pandemic Mitigation: Noninvasive Ventilators Market – 2020-2024………………………………………….. 303
31.2.1 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 303
31.2.2 Noninvasive Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 304
32 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024 305
32.1 Invasive Mechanical Ventilators Market Background…………………………………. 305
32.1.1 Introduction and Findings…………. 305
32.1.2 Challenges of Traditional Mechanical Ventilation Devices………………….. 312
32.1.2.1 Difficult To Expand Capacity And Limited Portability…………………. 312
32.1.2.2 Complex and Time Consuming To Administer Care……………………. 312
32.1.2.3 Difficult To Switch Between Therapies……………………………. 313
32.1.3 Invasive Mechanical Ventilators Market: Conclusions………………… 313
32.1.4 Invasive Mechanical Ventilators: Business Opportunities……………. 313
32.1.5 Invasive Mechanical Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution………. 315
32.1.6 Key Vendors………………………….. 316
32.2 Global COVID-19 Pandemic Mitigation: Invasive Mechanical Ventilators Market – 2020-2024………………………………….. 316
32.2.1 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 316
32.2.2 Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 317
33 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024 318
33.1 Next Generation Ventilators Market Background…………………………………. 318
33.1.1 Introduction and Findings…………. 318
33.1.2 Next Generation Ventilators Market: Conclusions…………………………… 319
33.1.3 Next Generation Ventilators: Business Opportunities…………………………. 320
33.1.4 Next Generation Ventilators: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution………. 321
33.2 Global COVID-19 Pandemic Mitigation: Next Generation Ventilators Market – 2020-2024………………………………….. 322
33.2.1 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 322
33.2.2 Next Generation Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 322
34 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 324
34.1 COVID-19 Homecare “ICU” (Equipment, Software, Services) Market Background…………………………………………………. 324
34.1.1 Introduction and Findings…………. 324
34.1.2 WHO Protocol For COVID-19 Homecare……………………………… 327
34.1.3 Homecare Market: Conclusions…. 328
34.1.4 Homecare Business Opportunities 329
34.1.5 Homecare: Competitive Analysis: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution……………………………. 330
34.1.6 Key Vendors………………………….. 331
34.2 Global COVID-19 Pandemic Mitigation: Homecare “ICU” (Equipment, Software, Services) Market – 2020-2024………… 331
34.2.1 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 332
34.2.2 Homecare “ICU” (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 332
34.3 Portable Ventilators Market Background…………………………………………………. 333
34.3.1 Introduction and Findings…………. 333
34.3.2 Portable Ventilators Market: Conclusions…………………………… 336
34.3.3 Key Vendors………………………….. 336
34.4 Global COVID-19 Pandemic Mitigation: Mobile Ventilators Market – 2020-2024…………………………………………………. 337
34.4.1 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 337
34.4.2 Mobile Ventilators COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 338
35 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024 339
35.1 Surge Capacity Hospitals Market Background…………………………………. 339
35.1.1 Introduction and Findings…………. 339
35.1.2 Surge Capacity Hospitals Market: Conclusions…………………………… 342
35.2 Global COVID-19 Pandemic Mitigation: Surge Capacity Hospitals Market – 2020-2024………………………………………….. 342
35.2.1 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 342
35.2.2 Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 343
36 Kidney Dialysis COVID-19 Pandemic Mitigation Market – 2020-2024…………….. 344
36.1 Kidney Dialysis Systems Market Background…………………………………. 344
36.1.1 Introduction and Findings…………. 344
36.1.2 Kidney Dialysis Systems Market: Conclusions…………………………… 347
36.1.3 Kidney Dialysis Systems: Business Opportunities…………………………. 347
36.1.4 Key Vendors………………………….. 347
36.2 Global COVID-19 Pandemic Mitigation: Kidney Dialysis Market – 2020-2024… 348
36.2.1 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 348
36.2.2 Kidney DialysisCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 349
37 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 350
37.1 Extracorporeal Membrane Oxygenation Procedures Market Background………. 350
37.1.1 Introduction and Findings…………. 350
37.1.2 The FDA Extracorporeal Membrane Oxygenation (ECMO) Policy……… 353
37.1.3 Extracorporeal Membrane Oxygenation Procedures Market: Conclusions…………………………… 354
37.1.4 Extracorporeal Membrane Oxygenation Procedures: Business Opportunities…………………………. 355
37.1.5 Key Vendors………………………….. 355
37.2 Global COVID-19 Pandemic Mitigation: Extracorporeal Membrane Oxygenation Procedures Market – 2020-2024……… 356
37.2.1 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 356
37.2.2 Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 356
38 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024 358
38.1 Other Intensive Care Modalities Market Background…………………………………. 358
38.1.1 Introduction and Findings…………. 358
38.1.2 Other Intensive Care Modalities Market: Conclusions………………… 361
38.2 Global COVID-19 Pandemic Mitigation: Other Intensive Care Modalities Market – 2020-2024………………………………….. 362
38.2.1 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 362
38.2.2 Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 362
39 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 364
39.1 PPE Gowns Manufacturing Plants Market Background…………………………………. 364
39.1.1 Introduction and Findings…………. 364
39.1.2 Gowns Manufacturing Plants Market: Conclusions…………………………… 366
39.1.3 Gowns Manufacturing Plants: Business Opportunities……………. 366
39.2 Global COVID-19 Pandemic Mitigation: Gowns Manufacturing Plants Market – 2020-2024………………………………….. 366
39.2.1 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 367
39.2.2 Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 367
40 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 369
40.1 Medical PPE Gloves Manufacturing Plants Market Background……………… 369
40.1.1 Introduction and Findings…………. 369
40.1.2 Medical PPE Gloves Manufacturing Plants Market: Conclusions……… 371
40.1.3 Medical PPE Gloves Manufacturing Plants: Business Opportunities….. 372
40.2 Global COVID-19 Pandemic Mitigation: Gloves Manufacturing Plants Market – 2020-2024………………………………….. 372
40.2.1 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………….. 373
40.2.2 Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………….. 373
41 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 375
41.1 Face Masks Manufacturing Plants Market Background…………………………………. 375
41.1.1 Introduction and Findings…………. 375
41.1.2 N95 Respirators Manufacturing…. 383
41.1.3 Face Masks Manufacturing Plants Market: Conclusions………………… 385
41.1.4 Face Masks Manufacturing Plants: Business Opportunities……………. 386
41.1.5 Key Vendors………………………….. 386
41.2 Global COVID-19 Pandemic Mitigation: Face Masks Manufacturing Plants Market – 2020-2024………………………………… 387
41.2.1 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 387
41.2.2 Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 387
42 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 389
42.1 Face Shields Manufacturing Plants Market Background………………………. 389
42.1.1 Introduction and Findings…………. 389
42.2 Global COVID-19 Pandemic Mitigation: Face Shields Manufacturing Plants Market – 2020-2024……………………… 391
42.2.1 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 391
42.2.2 Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 392
43 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 393
43.1 Serologic Test Kits Manufacturing Plants Market Background………………………. 393
43.1.1 Introduction and Findings…………. 393
43.1.2 Serologic Test Kits Manufacturing Plants Market: Conclusions……… 394
43.2 Global COVID-19 Pandemic Mitigation: Serologic Test Kits Manufacturing Plants Market – 2020-2024……………………… 395
43.2.1 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 395
43.2.2 Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 395
44 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 397
44.1 Melt-Blown PPE Fabric Manufacturing Plants Market Background……………… 397
44.1.1 Introduction and Findings…………. 397
44.1.2 Melt-Blown PPE Fabric. Manufacturing Plants Market: Conclusions…………………………… 401
44.2 Global COVID-19 Pandemic Mitigation: Melt-Blown PPE Fabric Manufacturing Plants Market – 2020-2024…………….. 402
44.2.1 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 403
44.2.2 Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 403
45 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 405
45.1 Spun-Bond PPE Fabric Manufacturing Plants Market Background……………… 405
45.1.1 Introduction and Findings…………. 405
45.1.2 Spun-Bond PPE Fabric Manufacturing Plants Market: Conclusions……… 406
45.2 Global COVID-19 Pandemic Mitigation: Spun-Bond PPE Fabric Manufacturing Plants Market – 2020-2024…………….. 408
45.2.1 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 408
45.2.2 Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 408
46 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 410
46.1 Market Background………………………. 410
46.2 Global COVID-19 Pandemic Mitigation: Self-collection PCR Test Kits Manufacturing Plants Market – 2020-2024…………………………………………………. 411
46.2.1 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A……………………. 411
46.2.2 Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B……………………. 412
47 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 413
47.1 Ventilators Manufacturing Plants Market Background…………………………………. 413
47.1.1 Introduction and Findings…………. 413
47.1.2 Ventilators Manufacturing Plants Market: Conclusions………………… 416
47.2 Global COVID-19 Pandemic Mitigation: Ventilators Manufacturing Plants Market – 2020-2024………………………………….. 417
47.2.1 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 418
47.2.2 Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 418
48 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 419
48.1 Global COVID-19 Pandemic Mitigation: PCR Reagents Manufacturing Plants Market – 2020-2024……………………… 419
48.1.1 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 419
48.1.2 PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 420
49 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024 421
49.1 Global COVID-19 Pandemic Mitigation: PCR Systems Manufacturing Plants Market – 2020-2024……………………… 421
49.1.1 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 421
49.1.2 PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 422
50 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 423
50.1 Nose & Mouth Swabs Manufacturing Plants Market Background……………… 423
50.1.1 Introduction and Findings…………. 423
50.1.2 Swabs Manufacturing Plants Market: Conclusions…………………………… 425
50.1.3 Swabs Manufacturing Plants: Business Opportunities……………. 426
50.2 Global COVID-19 Pandemic Mitigation: Nose & Mouth Swabs Manufacturing Plants Market – 2020-2024…………….. 426
50.2.1 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 427
50.2.2 Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 427
51 Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 428
51.1 Global COVID-19 Pandemic Mitigation: Medical Glass & Other Manufacturing Plants Market – 2020-2024…………….. 428
51.1.1 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 428
51.1.2 Medical Glass & Other Manufacturing PlantsCOVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 429
52 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024 430
52.1 Global COVID-19 Pandemic Mitigation: R&D Equipment & Consumables Market – 2020-2024………………………………….. 430
52.1.1 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A.. 430
52.1.2 R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B.. 431
53 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024……………………………. 432
53.1 Medical Glass and Other Products & Services Market Background………….. 432
53.1.1 Medical Glass Introduction and Findings………………………………… 432
53.1.2 Medical Glass Market: Conclusions……………………………………………. 433
53.1.3 Key Medical Glass Vendors………. 433
53.2 Global COVID-19 Pandemic Mitigation: Medical Glass and Other Products & Services Market – 2020-2024…………. 433
53.2.1 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario A…………………………….. 434
53.2.2 Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market – 2020-2024: Scenario B…………………………….. 434
[Back to top]
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 3
Download the PDF
VERTICAL MARKETS…………………………………. 14
1 Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market – 2020-2024.. 14
1.1 Market Background………………………… 14
1.2 Global COVID-19 Pandemic Mitigation: Hospitals and Surge Hospitals Market – 2020-2024……………………………………. 14
1.2.1 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario A…………………… 15
1.2.2 COVID-19 Pandemic Mitigation Hospitals and Surge Hospitals Market: Scenario B…………………… 16
1.2.3 Hospitals and Surge Hospitals Market: Scenarios Comparison…… 18
2 Clinical Labs COVID-19 Pandemic Mitigation Market – 2020-2024………………. 19
2.1 Market Background………………………… 19
2.2 Global COVID-19 Pandemic Mitigation: Clinical Labs Market – 2020-2024……… 19
2.2.1 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario A…. 20
2.2.2 COVID-19 Pandemic Mitigation Clinical Labs Market: Scenario B…. 21
2.2.3 Clinical Labs Market: Scenarios Comparison…………………………….. 23
3 Clinics COVID-19 Pandemic Mitigation Market – 2020-2024……………………………… 24
3.1 Market Background………………………… 24
3.2 Global COVID-19 Pandemic Mitigation: Clinics Market – 2020-2024……………… 24
3.2.1 COVID-19 Pandemic Mitigation Clinics Market: Scenario A…………. 25
3.2.2 COVID-19 Pandemic Mitigation Clinics Market: Scenario B…………. 26
3.2.3 Clinics Market: Scenarios Comparison……………………………………………… 28
4 Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market – 2020-2024 29
4.1 Market Background………………………… 29
4.2 Global COVID-19 Pandemic Mitigation: Emergency Medical Services (EMS) Market – 2020-2024……………………….. 29
4.2.1 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario A…………………… 30
4.2.2 COVID-19 Pandemic Mitigation Emergency Medical Services (EMS) Market: Scenario B…………………… 31
4.2.3 Emergency Medical Services Market: Scenarios Comparison………………. 33
5 Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market – 2020-2024.. 34
5.1 Market Background………………………… 34
5.2 Global COVID-19 Pandemic Mitigation: Homecare & Nursing Homes Market – 2020-2024……………………………………. 34
5.2.1 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario A………………………………. 35
5.2.2 COVID-19 Pandemic Mitigation Homecare & Nursing Homes Market: Scenario B………………………………. 36
5.2.3 Homecare & Nursing Homes Market: Scenarios Comparison………………. 38
6 Research Bodies COVID-19 Pandemic Mitigation Market – 2020-2024………………. 39
6.1 Market Background………………………… 39
6.2 Global COVID-19 Pandemic Mitigation: Research Bodies Market – 2020-2024.. 39
6.2.1 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario A……………………………………………… 40
6.2.2 COVID-19 Pandemic Mitigation Research Bodies Market: Scenario B……………………………………………… 41
6.2.3 Research Bodies Market: Scenarios Comparison…………………………….. 43
REGIONAL MARKETS………………………………… 44
7 North America COVID-19 Pandemic Mitigation Market – 2020-2024……………….. 44
7.1 North America Vertical Markets – 2020-2024……………………………………………. 44
7.1.1 North America COVID-19 Pandemic Mitigation Market: Scenario A……… 44
7.1.2 North America COVID-19 Pandemic Mitigation Market: Scenario B……… 46
7.1.3 Scenarios Comparison………………. 48
7.2 North America COVID-19 Pandemic Mitigation Market by Revenue Source – 2020-2024……………………………………. 49
7.2.1 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A…………………… 49
7.2.2 North America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B…………………… 51
8 Europe COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 53
8.1 Europe Vertical Markets – 2020-2024… 53
8.1.1 Europe COVID-19 Pandemic Mitigation Market: Scenario A……… 53
8.1.2 Europe COVID-19 Pandemic Mitigation Market: Scenario B……… 55
8.1.3 Scenarios Comparison………………. 57
8.2 Europe COVID-19 Market by Revenue Source – 2020-2024……………………….. 58
8.2.1 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario A…………………… 58
8.2.2 Europe COVID-19 Pandemic Mitigation Products & Services Market: Scenario B…………………… 60
9 Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 61
9.1 Asia-Pacific Vertical Markets – 2020-2024…………………………………………………… 61
9.1.1 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario A……… 61
9.1.2 Asia-Pacific COVID-19 Pandemic Mitigation Market: Scenario B……… 63
9.1.3 Scenarios Comparison………………. 64
9.2 Asia-Pacific COVID-19 Market by Revenue Source – 2020-2024………….. 65
9.2.1 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario A…………………… 65
9.2.2 Asia-Pacific COVID-19 Pandemic Mitigation Products & Services Market: Scenario B…………………… 67
10 MEA & Latin America COVID-19 Pandemic Mitigation Market – 2020-2024……………….. 69
10.1 MEA & Latin America Vertical Markets – 2020-2024……………………………………. 69
10.1.1 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario A…………………………………………… 69
10.1.2 MEA & Latin America COVID-19 Pandemic Mitigation Market: Scenario B…………………………………………… 71
10.1.3 Scenarios Comparison………………. 73
10.2 MEA & Latin America COVID-19 Market by Revenue Source – 2020-2024……… 74
10.2.1 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario A………. 74
10.2.2 MEA & Latin America COVID-19 Pandemic Mitigation Products & Services Market: Scenario B………. 76
NATIONAL MARKETS…………………………………. 78
11 USA COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 78
11.1 Market Background………………………… 78
11.2 USA COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 79
12 Canada COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 81
12.1 Market Background………………………… 81
12.2 Canada COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 82
13 U.K. COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 84
13.1 Market Background………………………… 84
13.2 U.K. COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 85
14 Germany COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 87
14.1 Market Background………………………… 87
14.2 Germany COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 88
15 France COVID-19 Pandemic Mitigation Market – 2020-2024………………………………. 90
15.1 Market Background………………………… 90
15.2 France COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 91
16 Italy COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 93
16.1 Market Background………………………… 93
16.2 Italy COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 94
17 Rest of Europe COVID-19 Pandemic Mitigation Market – 2020-2024……………….. 96
18 India COVID-19 Pandemic Mitigation Market – 2020-2024…………………………………………. 98
18.1 Market Background………………………… 98
18.2 India COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………….. 99
19 China COVID-19 Pandemic Mitigation Market – 2020-2024…………………………….. 101
19.1 Market Background………………………. 101
19.2 China COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………… 102
20 South Korea COVID-19 Pandemic Mitigation Market – 2020-2024…………………………….. 104
20.1 Market Background………………………. 104
20.2 South Korea COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024…………………………………………………. 105
21 Japan COVID-19 Pandemic Mitigation Market – 2020-2024…………………………….. 107
21.1 Market Background………………………. 107
21.2 Japan COVID-19 Pandemic Mitigation Market Scenarios– 2020-2024………… 108
22 Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market – 2020-2024……………… 110
23 ROW COVID-19 Pandemic Mitigation Market – 2020-2024……………………………………….. 112
[Back to top]
Global Homeland Security & Public Safety Market – 2020-2024: Volume 4
Download the PDF
MAJOR VENDORS……………………………………….. 8
1 Vendor 1………………………………………………. 8
1.1 Company Profile……………………………… 8
1.2 2017- 2019 Financials………………………. 8
1.3 COVID-19 Mitigation Activities & Products………………………………………… 9
2 Vendor 2…………………………………………….. 11
2.1 Company Profile……………………………. 11
2.2 2017- 2019 Financials…………………….. 11
2.3 COVID-19 Mitigation Activities & Products………………………………………. 12
3 Vendor 3…………………………………………….. 13
3.1 Company Profile……………………………. 13
3.2 2017- 2018 Financials…………………….. 13
3.3 COVID-19 Mitigation Activities & Products………………………………………. 14
4 Vendor 4…………………………………………….. 15
4.1 Company Profile……………………………. 15
4.2 2017- 2018 Financials…………………….. 15
4.3 COVID-19 Mitigation Activities & Products………………………………………. 16
5 Vendor 5…………………………………………….. 17
5.1 Company Profile……………………………. 17
5.2 2017- 2019 Financials…………………….. 17
5.3 COVID-19 Mitigation Activities & Products………………………………………. 17
6 Vendor 6…………………………………………….. 18
6.1 Company Profile……………………………. 18
6.2 2017- 2018 Financials…………………….. 18
6.3 COVID-19 Mitigation Activities & Products………………………………………. 18
7 Vendor 7…………………………………………….. 19
7.1 Company Profile……………………………. 19
7.2 2017- 2019 Financials…………………….. 19
7.3 COVID-19 Mitigation Activities & Products………………………………………. 20
8 Vendor 8…………………………………………….. 21
8.1 Company Profile……………………………. 21
8.2 2017- 2019 Financials…………………….. 21
8.3 COVID-19 Mitigation Activities & Products………………………………………. 22
9 Vendor 9…………………………………………….. 23
9.1 Company Profile……………………………. 23
9.2 2017- 2019 Financials…………………….. 24
9.3 COVID-19 Mitigation Activities & Products………………………………………. 24
10 Vendor 10…………………………………………… 26
10.1 Company Profile……………………………. 26
10.2 2017- 2019 Financials…………………….. 26
10.3 COVID-19 Mitigation Activities & Products………………………………………. 26
11 Vendor 11…………………………………………… 27
11.1 Company Profile……………………………. 27
11.2 2017- 2019 Financials…………………….. 27
11.3 COVID-19 Mitigation Activities & Products………………………………………. 28
12 Vendor 12…………………………………………… 29
12.1 Company Profile……………………………. 29
12.2 2017- 2019 Financials…………………….. 30
12.3 COVID-19 Mitigation Activities & Products………………………………………. 30
13 Vendor 13…………………………………………… 31
13.1 Company Profile……………………………. 31
13.2 2017- 2019 Financials…………………….. 31
13.3 COVID-19 Mitigation Activities & Products………………………………………. 32
14 Vendor 14…………………………………………… 33
14.1 Company Profile……………………………. 33
14.2 2017- 2019 Financials…………………….. 34
14.3 COVID-19 Mitigation Activities & Products………………………………………. 34
15 Vendor 15…………………………………………… 35
15.1 Company Profile……………………………. 35
15.2 2017- 2019 Financials…………………….. 36
15.3 COVID-19 Mitigation Activities & Products………………………………………. 36
16 Vendor 16…………………………………………… 37
16.1 Company Profile……………………………. 37
16.2 2017- 2019 Financials…………………….. 38
16.3 COVID-19 Mitigation Activities & Products………………………………………. 38
17 Vendor 17…………………………………………… 40
17.1 Company Profile……………………………. 40
17.2 2017- 2019 Financials…………………….. 40
17.3 COVID-19 Mitigation Activities & Products………………………………………. 41
18 Vendor 18…………………………………………… 42
18.1 Company Profile……………………………. 42
18.2 2017- 2019 Financials…………………….. 42
18.3 COVID-19 Mitigation Activities & Products………………………………………. 43
19 Vendor 19…………………………………………… 44
19.1 Company Profile……………………………. 44
19.2 2017- 2019 Financials…………………….. 44
19.3 COVID-19 Mitigation Activities & Products………………………………………. 44
20 Vendor 20…………………………………………… 45
20.1 Company Profile……………………………. 45
20.2 2016- 2018 Financials…………………….. 45
20.3 COVID-19 Mitigation Activities & Products………………………………………. 46
21 Vendor 21…………………………………………… 46
21.1 Company Profile……………………………. 47
21.2 2017- 2019 Financials…………………….. 47
21.3 COVID-19 Mitigation Activities & Products………………………………………. 48
22 Vendor 22…………………………………………… 49
22.1 Company Profile……………………………. 49
22.2 2017- 2019 Financials…………………….. 49
22.3 COVID-19 Mitigation Activities & Products………………………………………. 50
23 Vendor 23…………………………………………… 51
23.1 Company Profile……………………………. 51
23.2 2017- 2019 Financials…………………….. 51
23.3 COVID-19 Mitigation Activities & Products………………………………………. 52
24 Vendor 24…………………………………………… 52
24.1 Company Profile……………………………. 53
24.2 2017- 2019 Financials…………………….. 53
24.3 COVID-19 Mitigation Activities & Products………………………………………. 54
25 Vendor 25…………………………………………… 54
25.1 Company Profile……………………………. 55
25.2 2017- 2019 Financials…………………….. 55
25.3 COVID-19 Mitigation Activities & Products………………………………………. 56
26 Vendor 26…………………………………………… 56
26.1 Company Profile……………………………. 57
26.2 2017- 2019 Financials…………………….. 57
26.3 COVID-19 Mitigation Activities & Products………………………………………. 57
27 Vendor 27…………………………………………… 59
27.1 Company Profile……………………………. 59
27.2 2017- 2019 Financials…………………….. 60
27.3 COVID-19 Mitigation Activities & Products………………………………………. 60
28 Vendor 28…………………………………………… 61
28.1 Company Profile……………………………. 61
28.2 2017- 2019 Financials…………………….. 62
28.3 COVID-19 Mitigation Activities & Products………………………………………. 62
29 Vendor 29…………………………………………… 64
29.1 Company Profile……………………………. 64
29.2 2017- 2019 Financials…………………….. 64
29.3 COVID-19 Mitigation Activities & Products………………………………………. 65
30 Vendor 30…………………………………………… 66
30.1 Company Profile……………………………. 66
30.2 2017- 2019 Financials…………………….. 66
30.3 COVID-19 Mitigation Activities & Products………………………………………. 66
31 Vendor 31…………………………………………… 67
31.1 Company Profile……………………………. 67
31.2 2017- 2019 Financials…………………….. 67
31.3 COVID-19 Mitigation Activities & Products………………………………………. 67
32 Vendor 32…………………………………………… 68
32.1 Company Profile……………………………. 68
32.2 2017- 2019 Financials…………………….. 68
32.3 COVID-19 Mitigation Activities & Products………………………………………. 69
33 Vendor 33…………………………………………… 69
33.1 Company Profile……………………………. 70
33.2 2017- 2019 Financials…………………….. 70
33.3 COVID-19 Mitigation Activities & Products………………………………………. 71
34 Vendor 34…………………………………………… 71
34.1 Company Profile……………………………. 72
34.2 2008- 2010 Financials…………………….. 73
34.3 COVID-19 Mitigation Activities & Products………………………………………. 73
35 Vendor 35…………………………………………… 74
35.1 Company Profile……………………………. 74
35.2 2017- 2019 Financials…………………….. 74
35.3 COVID-19 Mitigation Activities & Products………………………………………. 75
36 Vendor 36…………………………………………… 75
36.1 Company Profile……………………………. 76
36.2 2017- 2019 Financials…………………….. 76
36.3 COVID-19 Mitigation Activities & Products………………………………………. 77
37 Vendor 37…………………………………………… 78
37.1 Company Profile……………………………. 78
37.2 2013- 2015 Financials…………………….. 78
37.3 COVID-19 Mitigation Activities & Products………………………………………. 79
[Back to top]
COVID-19 Pandemic Mitigation Products Market – 2020-2024: Volume 4
Download the PDF
APPENDICES…………………………………………….. 10
1 Appendix 1: Differences & Similarities Between Common Flu and Coronavirus… 10
1.1 Similarities:…………………………………… 10
1.2 Differences…………………………………… 10
2 Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel…………………………………………… 12
2.1 Introduction…………………………………… 12
2.2 Conclusions………………………………….. 13
2.3 Findings Summary…………………………. 15
2.4 Background………………………………….. 19
2.4.1 Description of the Condition……….. 19
2.4.2 Description of the Intervention…….. 20
2.4.3 How the Intervention Might Work…. 23
2.4.4 Why it Is Important To Do This Review…………………………………… 23
2.4.5 Summary………………………………… 24
3 Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection………………… 26
3.1 Introduction…………………………………… 26
3.1.1 Contingency Capacity Strategies………. 27
3.1.2 Extended Use Of Eye Protection…. 27
3.1.3 Crisis Capacity Strategies………….. 28
3.1.4 Selected Options for Reprocessing Eye Protection…………………………. 29
4 Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns……………… 29
4.1 Purpose……………………………………….. 29
4.2 Conventional Capacity Strategies……… 31
4.3 Contingency Capacity Strategies………. 31
4.4 Crisis Capacity Strategies……………….. 32
4.5 Extended Use of Isolation Gowns……… 33
4.5.1 Re-use of Cloth Isolation Gowns…. 33
4.5.2 Prioritize Gowns……………………….. 33
4.5.3 When No Gowns Are Available…… 34
5 Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks…………………….. 35
5.1 Purpose……………………………………….. 35
5.2 Conventional Capacity Strategies……… 36
5.3 Contingency Capacity Strategies………. 36
5.4 When No Facemasks Are Available, Options Include……………………………… 38
6 Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators……………… 40
7 Appendix 7: CDC Adult Vaccine Price List 43
7.1 CDC Vaccine 2020-2021 Price List……. 43
7.2 CDC Influenza Vaccine 2020-2021 Price List……………………………………………… 44
8 Appendix 8: The CDC COVID-19 Bio-Safety Guidelines………………………………………….. 46
8.1 The CDC Safety Practices for Critical Infrastructure Workers Exposed to a Person with Suspected or Confirmed COVID-19…………………………………….. 46
8.2 Use of Cloth Face Coverings……………. 46
8.3 The Emergency Medical Services Guidance……………………………………… 47
8.4 Recommendations for 911 PSAPs…….. 48
8.4.1 Modified Caller Queries……………… 48
8.5 EMS Clinicians and Medical First Responders………………………………….. 49
8.5.1 Patient assessment…………………… 49
8.6 Recommended Personal Protective Equipment……………………………………. 50
8.7 Precautions for Aerosol-Generating Procedures…………………………………… 51
8.8 EMS Transport of a PUI or Patient with Confirmed COVID-19 to a Healthcare Facility…………………………………………. 51
8.9 Documentation Of Patient Care………… 52
8.10 Cleaning EMS Transport Vehicles after Transporting a PUI or Patient with Confirmed COVID-19……………………… 53
8.11 Measures by EMS Clinicians After Caring for a PUI or Patient with Confirmed COVID-19…………………………………….. 54
8.12 EMS Employer Responsibilities………… 55
9 Appendix 9: The 2020 Global Desperation to Protect Medical Workers……………………… 56
10 Appendix 10: Disinfection Procedures for COVID-19……………………………………………. 59
10.1 Disinfection for Floor and Walls………… 59
10.2 Disinfection of Object Surfaces…………. 59
10.3 Air Disinfection………………………………. 59
10.4 Disposal of Fecal Matter and Sewage… 59
10.5 Disposal Procedures for Spills of COVID-19 Patient Blood/Fluids…………………… 60
11 Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020 61
11.1 Public Health and Social Services Emergency Fund – March 2020………… 61
11.2 For Advance Construction, Manufacture, And Purchase Of Vaccines And Therapeutic Delivery………………………. 61
11.3 Telehealth, Poison Control Centers, And The Ryan White HIV/AIDS Program….. 61
11.4 National Institutes of Health……………… 62
11.5 Substance Abuse and Mental Health Services Administration…………………… 62
11.6 Administration for Children and Families…………………………………………………… 63
11.7 Veterans Health Administration………… 63
12 Appendix 12: European Preparedness Against Emerging Epidemics……………….. 64
13 Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19……………………………………………. 66
13.1 Introduction…………………………………… 66
13.2 Diagnostic Tests……………………………. 69
13.1.1 IVD Tests………………………………… 69
13.1.2 LDT Tests……………………………….. 69
13.1.3 How are IVD Tests Regulated?…… 69
13.1.4 How are LDTs Regulated?…………. 70
13.1.5 What is CLIA and How Is It Involved in LDT Regulation?…………………… 70
13.1.6 How are IVDs Regulated by the FDA During an Emergency Such as the Outbreak of COVID-19?…………….. 71
13.1.7 How Does the Emergency Use Authority Apply to LDTs if They Are Generally Exempted from Premarket Requirements?………………………… 71
13.1.8 How Does the CDC’s COVID-19 Diagnostic Test Work?………………. 72
13.1.9 What Type of IVD is the CDC’s Test and Who May Carry it Out?………… 73
13.1.10 What Is the Role of the Commercial Manufacturer IDT in the Development and Distribution of the CDC’s Test Kit?………………………………………… 74
13.1.11 What Quality Problems Did the CDC’s Test Experience on Rollout to the State and Local Public Health Laboratories?…………………………… 74
13.1.12 What Steps did the FDA Take to Expand Testing Capacity in Response to the Problems with the CDC’s Test?……………………………………………… 75
14 Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization………………………………. 76
15 Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)……………………. 79
16 Appendix 16: Comparing Clinical COVID-19 Data by Nation……………………………………. 80
16.1 Introduction…………………………………… 80
16.2 Counting Deaths Protocols………………. 80
16.3 National Death Rates……………………… 81
16.4 National Political Factors…………………. 82
16.5 National Testing Protocols……………….. 83
16.6 Conclusions: Comparisons are Difficult. 84
17 Appendix 17: Home Healthcare IT…………. 85
17.1 Introduction…………………………………… 85
17.2 Online Bots…………………………………… 86
17.3 Home Telehealth……………………………. 86
17.4 Telemedicine Billing……………………….. 88
17.5 Commercial Insurance……………………. 88
18 Appendix 18: The Difference between PCR and Antibody Tests……………………………… 90
19 Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021……………….. 91
19.1 Introduction…………………………………… 91
19.2 Economic Effects…………………………… 93
19.3 USA…………………………………………….. 95
19.4 Europe…………………………………………. 96
19.5 The UK………………………………………… 97
19.6 Japan………………………………………….. 98
19.7 China…………………………………………… 98
19.8 The IMF……………………………………….. 98
19.9 The World Bank…………………………….. 99
19.10 Emerging Markets………………………… 100
19.11 Other Sectors………………………………. 101
20 Appendix 20: COVID-19 Tests…………….. 103
20.1 COVID-19 Tests Sensitivity and Specificity…………………………………… 103
20.2 RT-PCR tests………………………………. 104
20.3 Antibody Tests…………………………….. 105
20.4 Other Diagnostic Options………………. 108
20.5 Procurement of Test Kits and Consumables………………………………. 108
20.6 Annex A: Test Kit Options from WHO Diagnostics Consortium…………………. 109
21 Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region………………………. 118
22 Appendix 22: Abbreviations……………….. 125
23 Appendix 23: Glossary………………………. 129
24 Appendix 24: Bibliography…………………. 136
25 Research Methodology………………………. 242
25.1 Scope………………………………………… 242
25.2 Research Methodology………………….. 242
26 Disclaimer & Copyright………………………. 245
Tables
5 Volumes:
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 1
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 2
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 3
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 4
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 5
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 1
Table 1 – COVID-19 June 1, 2020 COVID-19 Cases and the Number Dead per Million by Country.. 26
Table 2 – Global Products & Services Groups Markets’ Size [$M]: Scenario A – 2020-2024………. 46
Table 3 – Global Products & Services Groups Markets’ Size [$M]: Scenario B – 2020-2024………. 47
Table 4 – Global Products & Services Markets’ Size [$M]: Scenario A – 2020-2024……………………… 50
Table 5 – Global Products & Services Markets’ Size [$M]: Scenario B – 2020-2024……………………… 52
Table 6 – Global Vertical Markets’ Size [$M]: Scenario A – 2020-2024………………………………………. 54
Table 7 – Global Vertical Markets’ Size [$M]: Scenario B – 2020-2024………………………………………. 54
Table 8 – Global Market Size by Revenue Source [$M] Scenario A – 2020-2024……………………… 55
Table 9 – Global Market Size by Revenue Source [$M] Scenario B – 2020-2024……………………… 55
Table 10 – Regional Markets Size [$M]: Scenario A – 2020-2024………………………………………. 55
Table 11 – Regional Markets Size [$M]: Scenario B – 2020-2024………………………………………. 56
Table 12 – National Markets Size [$M]: Scenario A – 2020-2024………………………………………. 56
Table 13 – National Markets Size [$M]: Scenario B – 2020-2024………………………………………. 57
Table 14 – COVID-19 Pandemic Mitigation Products Market: Business Opportunities…………… 81
Table 15 – Global Products & Services Groups Markets’ Size [$M]: Scenario A – 2020-2024………. 87
Table 16 – Global Products & Services Groups Markets’ Dynamics [%]: Scenario A – 2020-2024…. 89
Table 17 – Global Products & Services Groups Markets’ Size [$M]: Scenario B – 2020-2024………. 90
Table 18 – Global Products & Services Groups Markets’ Dynamics [%]: Scenario B – 2020-2024…. 91
Table 19 – Global Products & Services Markets’ Size [$M]: Scenario A – 2020-2024……………… 94
Table 20 – Global Products & Services Markets’ Dynamics [%]: Scenario A – 2020-2024…. 96
Table 21 – Global Products & Services Markets’ Size [$M]: Scenario B – 2020-2024……………… 98
Table 22 – Global Products & Services Markets’ Dynamics [%]: Scenario B – 2020-2024.. 101
Table 23 – Global Vertical Markets’ Size [$M]: Scenario A – 2020-2024…………………………………… 104
Table 24 – Global Vertical Markets’ Dynamics [%]: Scenario A – 2020-2024……………………. 105
Table 25 – Global Vertical Markets’ Size [$M]: Scenario B – 2020-2024…………………………………… 106
Table 26 – Global Vertical Markets’ Dynamics [%]: Scenario B – 2020-2024……………………. 106
Table 27 – Global Market Size by Revenue Source [$M] Scenario A – 2020-2024……………………. 108
Table 28 – Global Markets Dynamics by Revenue Source [%]: Scenario A – 2020-2024……………… 108
Table 29 – Global Market Size by Revenue Source [$M] Scenario B – 2020-2024……………………. 109
Table 30 – Global Markets Dynamics by Revenue Source [%]: Scenario B – 2020-2024……………… 110
Table 31 – Regional Markets Size [$M]: Scenario A – 2020-2024……………………………………… 112
Table 32 – Regional Markets Dynamics by Region [%]: Scenario A – 2020-2024……………………. 112
Table 33 – Regional Markets Size [$M]: Scenario B – 2020-2024……………………………………… 113
Table 34 – Regional Markets Dynamics [%]: Scenario B – 2020-2024……………………………………… 114
Table 35 – National Markets Size [$M]: Scenario A – 2020-2024……………………………………… 116
Table 36 – National Markets Dynamics [%]: Scenario A – 2020-2024……………………………………… 118
Table 37 – National Markets Size [$M]: Scenario B – 2020-2024……………………………………… 119
Table 38 – National Markets Dynamics [%]: Scenario B – 2020-2024……………………………………… 121
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 2
Table 1 – Adult Vaccine 2020-2021 Price List………….. 48
Table 2 – Adult Influenza Vaccine 2020-2021 Price List……………………………………………………… 49
Table 3 – Vaccines Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024…. 58
Table 4 – Vaccines Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024…. 59
Table 5 – Therapeutic Drugs Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………………. 74
Table 6 – Therapeutic Drugs Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………………. 75
Table 7 – Other Pharma Industry Products Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………….. 80
Table 8 – Other Pharma Industry Products Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………….. 80
Table 9 – PCR Instrumentation & Software Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………….. 97
Table 10 – PCR Instrumentation & Software Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………….. 97
Table 11 – Robotic PCR Systems & Software Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 105
Table 12 – Robotic PCR Systems & Software Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 106
Table 13 – PCR Reagents & Consumables Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 111
Table 14 – PCR Reagents & Consumables Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 112
Table 15 – Nose & Mouth Swabs Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 117
Table 16 – Nose & Mouth Swabs Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 117
Table 17 – Self-collection PCR Test Kits Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 123
Table 18 – Self-collection PCR Test Kits Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 123
Table 19 – Serologic Test Kits Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 139
Table 20 – Serologic Test Kits Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 140
Table 21 – Standoff Thermometry Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 146
Table 22 – Standoff Thermometry Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 146
Table 23 – X-Ray Procedures Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 154
Table 24 – X-Ray Procedures Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 154
Table 25 – CT Procedures Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………………………. 160
Table 26 – CT Procedures Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………………………. 160
Table 27 – Ultrasound Procedures Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 167
Table 28 – Ultrasound Procedures Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 167
Table 29 – FDG-PET/CT Procedures & Wastewater Testing Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 174
Table 30 – FDG-PET/CT Procedures & Wastewater Testing Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 174
Table 31 – PACS & Teleradiology Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 183
Table 32 – PACS & Teleradiology Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 183
Table 33 – PPE Gowns Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 191
Table 34 – PPE Gowns Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 192
Table 35 – Gloves Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 195
Table 36 – Gloves Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 196
Table 37 – Face Masks Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 206
Table 38 – Face Masks Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 206
Table 39 – Medical Face Shields Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 210
Table 40 – Medical Face Shields Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 211
Table 41 – Eye Protection Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………………………. 214
Table 42 – Eye Protection Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………………………. 215
Table 43 – PPE Sterilization: Systems & Consumables Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………….. 216
Table 44 – PPE Sterilization: Systems & Consumables Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………….. 217
Table 45 – Hand & Surface Sanitizers Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 221
Table 46 – Hand & Surface Sanitizers Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 222
Table 47 – Decontamination Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 229
Table 48 – Decontamination Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 229
Table 49 – Other Personal Protection Gear Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 231
Table 50 – Other Personal Protection Gear Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 232
Table 51 – AI, Big Data & Deep Learning Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 250
Table 52 – AI, Big Data & Deep Learning Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 250
Table 53 – Homecare IT Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 255
Table 54 – Homecare IT Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 255
Table 55 – Use of Pandemic Geo-Location Data by Country…………………………………………. 260
Table 56 – Geo-Surveillance Systems & Services Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 271
Table 57 – Geo-Surveillance Systems & Services Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 271
Table 58 – E-Health Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 276
Table 59 – E-Health Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 276
Table 60 – Blockchain Technologies Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 284
Table 61 – Blockchain Technologies Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 285
Table 62 – Other ICT Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 291
Table 63 – Other ICT Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 291
Table 64 – Procurement Contracts on Non-Invasive Ventilators with Ten Vendors…………….. 299
Table 65 – Noninvasive Ventilators Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 303
Table 66 – Noninvasive Ventilators Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 304
Table 67 – Invasive Mechanical Ventilators Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 316
Table 68 – Invasive Mechanical Ventilators Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 317
Table 69 – Next Generation Ventilators Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 322
Table 70 – Next Generation Ventilators Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 322
Table 71 – Homecare “ICU” (Equipment, Software, Services) Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 332
Table 72 – Homecare “ICU” (Equipment, Software, Services) Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 332
Table 73 – Mobile Ventilators Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 337
Table 74 – Mobile Ventilators Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 338
Table 75 – Surge Capacity Hospitals Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………… 342
Table 76 – Surge Capacity Hospitals Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………… 343
Table 77 – Kidney Dialysis Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………………………. 348
Table 78 – Kidney Dialysis Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………………………. 349
Table 79 – Extracorporeal Membrane Oxygenation Procedures Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………………………………………. 356
Table 80 – Extracorporeal Membrane Oxygenation Procedures Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………………………………………. 356
Table 81 – Other Intensive Care Modalities Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 362
Table 82 – Other Intensive Care Modalities Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 362
Table 83 – Gowns Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 367
Table 84 – Gowns Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 367
Table 85 – Gloves Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 373
Table 86 – Gloves Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………………………………… 373
Table 87 – Face Masks Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 387
Table 88 – Face Masks Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 387
Table 89 – Face Shields Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 391
Table 90 – Face Shields Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 392
Table 91 – Serologic Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………….. 395
Table 92 – Serologic Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………….. 395
Table 93 – Melt-Blown PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………….. 403
Table 94 – Melt-Blown PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………….. 403
Table 95 – Spun-Bond PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………….. 408
Table 96 – Spun-Bond PPE Fabric Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………….. 408
Table 97 – Self-collection PCR Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 411
Table 98 – Self-collection PCR Test Kits Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 412
Table 99 – Ventilators Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………………………………… 418
Table 100 – Ventilators Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 418
Table 101 – PCR Reagents Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 419
Table 102 – PCR Reagents Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 420
Table 103 – PCR Systems Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 421
Table 104 – PCR Systems Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 422
Table 105 – Nose & Mouth Swabs Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………….. 427
Table 106 – Nose & Mouth Swabs Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………….. 427
Table 107 – Medical Glass & Other Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024………….. 428
Table 108 – Medical Glass & Other Manufacturing Plants Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024………….. 429
Table 109 – R&D Equipment & Consumables Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024……………………. 430
Table 110 – R&D Equipment & Consumables Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024……………………. 431
Table 111 – Medical Glass and Other Products & Services Market Size, Market Dynamics & Market Share: Scenario A – 2020-2024.. 434
Table 112 – Medical Glass and Other Products & Services Market Size, Market Dynamics & Market Share: Scenario B – 2020-2024.. 434
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 3
Table 1 – Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario A – 2020-2024…… 15
Table 2 – Hospitals and Surge Hospitals Market Dynamics by Region [%]: Scenario A – 2020-2024………………………………………. 15
Table 3 – Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario B – 2020-2024…… 16
Table 4 – Hospitals and Surge Hospitals Market Dynamics by Region [%]: Scenario B – 2020-2024………………………………………. 17
Table 5 – Clinical Labs Market Size by Region [$M]: Scenario A – 2020-2024……………………… 20
Table 6 – Clinical Labs Market Dynamics by Region [%]: Scenario A – 2020-2024……………………… 20
Table 7 – Clinical Labs Market Size by Region [$M]: Scenario B – 2020-2024……………………… 21
Table 8 – Clinical Labs Market Dynamics by Region [%]: Scenario B – 2020-2024……………………… 22
Table 9 – Clinics Market Size by Region [$M]: Scenario A – 2020-2024…………………………………….. 25
Table 10 – Clinics Market Dynamics by Region [%]: Scenario A – 2020-2024……………………… 25
Table 11 – Clinics Market Size by Region [$M]: Scenario B – 2020-2024………………………………….. 26
Table 12 – Clinics Market Dynamics by Region [%]: Scenario B – 2020-2024……………………… 27
Table 13 – Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario A – 2020-2024………………………………………………. 30
Table 14 – Emergency Medical Services (EMS) Market Dynamics by Region [%]: Scenario A – 2020-2024………………………………………. 30
Table 15 – Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario B – 2020-2024………………………………………………. 31
Table 16 – Emergency Medical Services (EMS) Market Dynamics by Region [%]: Scenario B – 2020-2024………………………………………. 32
Table 17 – Homecare & Nursing Homes Market Size by Region [$M]: Scenario A – 2020-2024…… 35
Table 18 – Homecare & Nursing Homes Market Dynamics by Region [%]: Scenario A – 2020-2024… 35
Table 19 – Homecare & Nursing Homes Market Size by Region [$M]: Scenario B – 2020-2024…… 36
Table 20 – Homecare & Nursing Homes Market Dynamics by Region [%]: Scenario B – 2020-2024… 37
Table 21 – Research Bodies Market Size by Region [$M]: Scenario A – 2020-2024……………………… 40
Table 22 – Research Bodies Market Dynamics by Region [%]: Scenario A – 2020-2024……………….. 40
Table 23 – Research Bodies Market Size by Region [$M]: Scenario B – 2020-2024……………………… 41
Table 24 – Research Bodies Market Dynamics by Region [%]: Scenario B – 2020-2024……………….. 42
Table 25 – North America Vertical Markets’ Size [$M]: Scenario A – 2020-2024……………………… 45
Table 26 – North America Vertical Markets’ Dynamics [%]: Scenario A – 2020-2024……………………… 45
Table 27 – North America Vertical Markets’ Size [$M]: Scenario B – 2020-2024……………………… 46
Table 28 – North America Vertical Markets’ Dynamics [%]: Scenario B – 2020-2024……………………… 47
Table 29 – North America Market Size by Revenue Source [$M] Scenario A – 2020-2024……. 49
Table 30 – North America Markets Dynamics by Revenue Source [%]: Scenario A – 2020-2024…….. 50
Table 31 – North America Market Size by Revenue Source [$M] Scenario B – 2020-2024……. 51
Table 32 – North America Markets Dynamics by Revenue Source [%]: Scenario B – 2020-2024…….. 52
Table 33 – Europe Vertical Markets’ Size [$M]: Scenario A – 2020-2024…………………………………….. 54
Table 34 – Europe Vertical Markets’ Dynamics [%]: Scenario A – 2020-2024……………………… 54
Table 35 – Europe Vertical Markets’ Size [$M]: Scenario B – 2020-2024…………………………………….. 55
Table 36 – Europe Vertical Markets’ Dynamics [%]: Scenario B – 2020-2024……………………… 56
Table 37 – Europe Market Size by Revenue Source [$M] Scenario A – 2020-2024……………………… 58
Table 38 – Europe Markets Dynamics by Revenue Source [%]: Scenario A – 2020-2024……………….. 59
Table 39 – Europe Market Size by Revenue Source [$M] Scenario B – 2020-2024……………………… 60
Table 40 – Europe Markets Dynamics by Revenue Source [%]: Scenario B – 2020-2024……………….. 60
Table 41 – Asia-Pacific Vertical Markets’ Size [$M]: Scenario A – 2020-2024……………………… 61
Table 42 – Asia-Pacific Vertical Markets’ Dynamics [%]: Scenario A – 2020-2024……………………… 62
Table 43 – Asia-Pacific Vertical Markets’ Size [$M]: Scenario B – 2020-2024……………………… 63
Table 44 – Asia-Pacific Vertical Markets’ Dynamics [%]: Scenario B – 2020-2024……………………… 63
Table 45 – Asia-Pacific Market Size by Revenue Source [$M] Scenario A – 2020-2024………………. 65
Table 46 – Asia-Pacific Markets Dynamics by Revenue Source [%]: Scenario A – 2020-2024…….. 66
Table 47 – Asia-Pacific Market Size by Revenue Source [$M] Scenario B – 2020-2024………………. 67
Table 48 – Asia-Pacific Markets Dynamics by Revenue Source [%]: Scenario B – 2020-2024…….. 68
Table 49 – MEA & Latin America Vertical Markets’ Size [$M]: Scenario A – 2020-2024……………… 70
Table 50 – MEA & Latin America Vertical Markets’ Dynamics [%]: Scenario A – 2020-2024…. 70
Table 51 – MEA & Latin America Vertical Markets’ Size [$M]: Scenario B – 2020-2024……………… 71
Table 52 – MEA & Latin America Vertical Markets’ Dynamics [%]: Scenario B – 2020-2024…. 72
Table 53 – MEA & Latin America Market Size by Revenue Source [$M] Scenario A – 2020-2024……. 74
Table 54 – MEA & Latin America Markets Dynamics by Revenue Source [%]: Scenario A – 2020-2024………………………………………………. 75
Table 55 – MEA & Latin America Market Size by Revenue Source [$M] Scenario B – 2020-2024……. 76
Table 56 – MEA & Latin America Markets Dynamics by Revenue Source [%]: Scenario B – 2020-2024………………………………………………. 77
Table 57 – USA Market Size, Dynamics and Share: Scenario A – 2020-2024……………………… 79
Table 58 – USA Market Size, Dynamics and Share: Scenario B – 2020-2024……………………… 80
Table 59 – Canada Market Size, Dynamics and Share: Scenario A – 2020-2024……………………… 83
Table 60 – Canada Market Size, Dynamics and Share: Scenario B – 2020-2024……………………… 83
Table 61 – U.K. Market Size, Dynamics and Share: Scenario A – 2020-2024……………………… 86
Table 62 – U.K. Market Size, Dynamics and Share: Scenario B – 2020-2024……………………… 86
Table 63 – Germany Market Size, Dynamics and Share: Scenario A – 2020-2024……………………… 89
Table 64 – Germany Market Size, Dynamics and Share: Scenario B – 2020-2024……………………… 89
Table 65 – France Market Size, Dynamics and Share: Scenario A – 2020-2024……………………… 92
Table 66 – France Market Size, Dynamics and Share: Scenario B – 2020-2024……………………… 92
Table 67 – Italy Market Size, Dynamics and Share: Scenario A – 2020-2024……………………… 95
Table 68 – Italy Market Size, Dynamics and Share: Scenario B – 2020-2024……………………… 95
Table 69 – Rest of Europe Market Size, Dynamics and Share: Scenario A – 2020-2024…………… 96
Table 70 – Rest of Europe Market Size, Dynamics and Share: Scenario B – 2020-2024…………… 96
Table 71 – India Market Size, Dynamics and Share: Scenario A – 2020-2024……………………. 100
Table 72 – India Market Size, Dynamics and Share: Scenario B – 2020-2024……………………. 100
Table 73 – China Market Size, Dynamics and Share: Scenario A – 2020-2024……………………. 103
Table 74 – China Market Size, Dynamics and Share: Scenario B – 2020-2024……………………. 103
Table 75 – South Korea Market Size, Dynamics and Share: Scenario A – 2020-2024………….. 105
Table 76 – South Korea Market Size, Dynamics and Share: Scenario B – 2020-2024………….. 106
Table 77 – Japan Market Size, Dynamics and Share: Scenario A – 2020-2024……………………. 109
Table 78 – Japan Market Size, Dynamics and Share: Scenario B – 2020-2024……………………. 109
Table 79 – Rest of Asia-Pacific Market Size, Dynamics and Share: Scenario A – 2020-2024……. 110
Table 80 – Rest of Asia-Pacific Market Size, Dynamics and Share: Scenario B – 2020-2024……. 110
Table 81 – ROW Market Size, Dynamics and Share: Scenario A – 2020-2024……………………. 112
Table 82 – ROW Market Size, Dynamics and Share: Scenario B – 2020-2024……………………. 112
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 4
This Volume contains no tables.
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 5
Table 1 – Summary of Findings for the Main Comparison. PPE-Types: One Type of PPE versus Another – PAPR versus E-RCP Attire………………………………………………. 15
Table 2 – Summary of Findings 2. PPE Types: One Type of PPE versus Another – Three Types of PPE Attire……………………………………….. 15
Table 3 – Summary of Findings 3. PPE Types: One Type of PPE versus Another – Gowns versus Aprons……………………………………………. 16
Table 4 – Summary of Findings 5. PPE Types: One Type of PPE versus Another - Sealed Suit Compared To Traditional Suit……………… 16
Table 5 – Summary of Findings 6. Procedures: Doffing With Double Gloves versus Doffing With Single Gloves…………………………………… 17
Table 6 – Summary of Findings 8. Procedures: Mask Tabs versus No Mask Tabs………………… 17
Table 7 – Summary of Findings 9. Procedures: Doffing According To CDC Method versus Individual Doffing……………………………………………. 17
Table 8 – Summary of Findings 10. Procedures: Doffing With Hypochlorite versus Doffing With Alcohol-Based Glove Sanitizer……………. 18
Table 9 – Summary of Findings 11. Procedures: Doffing With Chlorine Spray versus Doffing Without Spray……………………………………………… 18
Table 10 – Summary of Findings 12. Teaching: Video-Based Learning versus Traditional Lecture……………………………………………………… 18
Table 11 – CDC Vaccine 2020-2021 Price List………….. 43
Table 12 – CDC Influenza Vaccine 2020-2021 Price List……………………………………………………… 44
Table 13 – The OECD Global Economic Outlook Forecast, 2019-2021…………………………. 92
Figures
5 Volumes:
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 1
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 2
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 3
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 4
COVID-19 Pandemic Mitigation Products Market- 2020-2024 – Volume 5
COVID-19 Pandemic Mitigation Products Market – Volume 1
Figure 1 – Mortality Rate Comparison, MERS, SARS & COVID-19……………………………………….. 11
Figure 2 – COVID-19 Vs. Other Pandemics: Ro & Fatality Rate……………………………………………….. 13
Figure 3 – The Effect of the PRC Draconic Social Distancing Policy………………………………. 13
Figure 4 – Healthcare Expenditure [$B] by County – 2019……………………………………………………… 14
Figure 5 – Lower and Delay the Pandemic Peak Strategy……………………………………………………… 20
Figure 6 – The 10 Countries with the Most Foreign Drug Establishments Shipping to the United States as of 2019, by Country……………… 21
Figure 7 – Number of (2019) Intensive Care Beds [000] by Country…………………………………………… 22
Figure 8 – ICU Beds (2019) Per 100,000 Inhabitants, by Country…………………………………………… 23
Figure 9 – The WHO Research Funding ($8.5 Billion) Allocation………………………………………… 28
Figure 10 – A Serologic Test Kit…………………………….. 35
Figure 11 – Modeling COVID-19 Pandemic: ‘Uncertainty is the Only Certainty’…………………………. 37
Figure 12 – The Way an Application Detects a Person w/o Symptoms……………………………………….. 38
Figure 13 – Countries Enacting Geo-Surveillance Services to Mitigate the COVID-19 Pandemic………………………………………… 39
Figure 14 – COVID-19 Pandemic Impact on Global Economics & Geopolitics……………………. 41
Figure 15 – Global COVID-19 Pandemic Mitigation Products Market Vectors……………………. 45
Figure 16 – Global Products & Services Groups Markets’ Size [$M]: Scenario A – 2020-2024………. 47
Figure 17 – Global Products & Services Groups Markets’ Size [$M]: Scenario B – 2020-2024………. 48
Figure 18 – Global Products & Services Markets’ Size [$M]: Scenarios A and B – 2020-2024…… 49
Figure 19 – The SARS-CoV-2 Virus………………………… 58
Figure 20 – Epidemics & Pandemics Historical Timeline……………………………………………………… 60
Figure 21 – COVID-19 Ro & Fatality Rate Vs. Other Pandemics Ro & Fatality Rate…………….. 62
Figure 22 – How Herd Immunity Can Stop the COVID-19……………………………………………………… 63
Figure 23 – The Effect of an Pandemic Early Stage Using “Social Distancing” Measures……………… 63
Figure 24 – The SARS-CoV-2, Size, Content, Genome and Replication Timescales………………… 64
Figure 25 – Serology Test Process…………………………. 72
Figure 26: COVID-19 Pandemic Mitigation Products Industry Value Chain…………………………. 83
Figure 27 – COVID-19 Pandemic Mitigation Products Security Systems Market Competitive Analysis………………………………………….. 86
Figure 28 – Global Products & Services Groups Markets’ Size [$M]: Scenario A – 2020-2024………. 88
Figure 29 – Global Products & Services Groups Market Shares [%]: Scenario A – 2020-2024…….. 89
Figure 30 – Global Products & Services Groups Markets’ Size [$M]: Scenario B – 2020-2024………. 91
Figure 31 – Global Products & Services Groups Market Shares [%]: Scenario B – 2020-2024…….. 92
Figure 32 – Global COVID-19 Mitigation Market Size [$M]: Scenarios A and B – 2020-2024…………… 92
Figure 33 – Global Products & Services Markets’ Size [$M]: Scenarios A and B – 2020-2024…. 103
Figure 34 – Global Vertical Markets’ Shares [%]: Scenario A – 2020-2024………………………………… 105
Figure 35 – Global Vertical Markets’ Shares [%]: Scenario B – 2020-2024………………………………… 107
Figure 36 – Global Vertical Markets’ Size [$M]: Scenarios A and B – 2020-2024……………………….. 107
Figure 37 – Global Market Shares by Revenue Source [%]: Scenario A – 2020-2024…………………. 109
Figure 38 – Global Market Shares by Revenue Source [%]: Scenario B – 2020-2024…………………. 110
Figure 39 – Global Revenue Sources [$M]: Scenarios A and B – 2020-2024…………………………… 111
Figure 40 – Regional Market Shares [%]: Scenario A – 2020-2024……………………………………… 113
Figure 41 – Regional Market Shares [%]: Scenario B – 2020-2024……………………………………… 114
Figure 42 – Regional Markets’ Size [$M]: Scenarios A and B – 2020-2024………………………………… 115
Figure 43 – National Markets Size [$M]: Scenario A – 2020-2024……………………………………… 117
Figure 44 – National Markets Shares [%]: Scenario A – 2020-2024……………………………………… 118
Figure 45 – National Markets Size [$M]: Scenario B – 2020-2024……………………………………… 120
Figure 46 – National Markets Shares [%]: Scenario B – 2020-2024……………………………………… 122
Figure 47 – COVID-19 National Markets Size [$M]: Scenarios A and B – 2020-2024…………. 122
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 2
Figure 1 – Vaccine Development: Traditional Timeline vs. COVID-19 Accelerated Timeline………….. 34
Figure 2 – COVID-19 Vaccines Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………… 54
Figure 3 – Vaccines Market Size [$M] by Scenario – 2020-2024………………………………………………. 59
Figure 4 – FDA Testing COVID-19 Treatment…………… 62
Figure 5 – Network-Based Drug Repurposing For COVID-19………………………………………………….. 64
Figure 6 – COVID-19 Therapeutic Drug Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………… 70
Figure 7 – COVID-19 Therapeutic Drugs Market Size [$M] by Scenario – 2020-2024……………………. 75
Figure 8- Medicines Essential for ICU Care of COVID-19 Patients Are Prepped For Shipment in Direct Relief’s Warehouse………………….. 76
Figure 9 – Other COVID-19 Pharma Industry Products Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………… 79
Figure 10 – Other Pharma Industry Products Market Size [$M] by Scenario – 2020-2024……………… 81
Figure 11 – Reverse Transcription – Polymerase Chain Reaction (RT-PCR) Process……………….. 83
Figure 12- PCR Test……………………………………………. 84
Figure 13 – PCR Thermal Amplification…………………… 85
Figure 14 – Antibody Vs. PCR Testing Methods………… 87
Figure 15 – RT-PCR Process………………………………… 89
Figure 16 – COVID-19 PCR Components………………… 91
Figure 17 – PCR Instrumentation & Software Market: Barriers to Entry, Supplier Power, Buyer Power and Barriers to Substitution……….. 95
Figure 18 – PCR Instrumentation & Software Market Size [$M] by Scenario – 2020-2024……………… 97
Figure 19 – Robotic COVID-19 PCR Lab Can Process 1000 Patient Samples Daily………………. 100
Figure 20 – A Robotic PCR Lab Can Provide Much Needed Testing Capacity For Those With Symptoms Consistent With COVID-19 Infection………………………………………… 101
Figure 21 – Thermo Fisher Robotic Based Lab Automation…………………………………….. 101
Figure 22 – Robotic PCR Systems & Software Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution…………………….. 104
Figure 23 – Robotic PCR Systems & Software Market Size [$M] by Scenario – 2020-2024…….. 106
Figure 24 – COVID-19 PCR Kit…………………………….. 107
Figure 25 – PCR Reagents & Consumables Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution…………………….. 110
Figure 26 – PCR Reagents & Consumables Market Size [$M] by Scenario – 2020-2024……………. 112
Figure 27 – Nose & Mouth Swabs Collecting Procedure……………………………………………………. 113
Figure 28 – PCR Sample Using Nose & Mouth Swabs 114
Figure 29 – Nose & Mouth Swabs Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………. 116
Figure 30 – Nose & Mouth Swabs Market Size [$M] by Scenario – 2020-2024………………………. 118
Figure 31 – An Oral Self-Swab Kit…………………………. 119
Figure 32 – Saliva Test Vials……………………………….. 121
Figure 33 – FDA Approved Saliva Test………………….. 122
Figure 34 – Self-collection PCR Test Kits Market Size [$M] by Scenario – 2020-2024……………. 123
Figure 35 – A Serologic Test Kit……………………………. 124
Figure 36 – How a Serologic Test Works……………….. 125
Figure 37 – Antibody Vs. PCR Testing Methods………. 128
Figure 38 – The Indian Government’s Proposed COVID-19 Antibody Screening Flowchart……….. 129
Figure 39 – Coronavirus Antibody Test Kit……………… 131
Figure 40 – Coronavirus IgG Antibody Detection Kit Reading………………………………………… 131
Figure 41 – Serologic Test Kits Market: Barriers to Entry, Supplier Power, Buyer Power and Substitution……………………………………. 138
Figure 42 – Serologic Test Kits Market Size [$M] by Scenario – 2020-2024………………………. 140
Figure 43 – COVID-19 Standoff Thermometry Screening……………………………………………………. 141
Figure 44 – Body Temperature Measuring & Facial Recognition Access Control………………. 142
Figure 45 – A Standoff Thermal Camera………………… 143
Figure 46 – A Standoff Thermometer Kit………………… 144
Figure 47 – Standoff Thermometry Market Size [$M] by Scenario – 2020-2024………………………. 146
Figure 48 – A Mobile X-Ray System……………………… 148
Figure 49 – A Series of Chest X-Ray Findings of Patient With COVID-19 Demonstrating Clinical Characteristics of Disease………………… 149
Figure 50 – Partial Filling of Air Spaces in The Lungs From Coronavirus……………………………. 150
Figure 51 – X-Ray Procedures Market Size [$M] by Scenario – 2020-2024………………………. 154
Figure 52 – The Vatech COVID-19 Dedicated CT System……………………………………………………. 155
Figure 53 – Chest CT images of A COVID-19 Patient. Top Five Days after Onset, Bottom 15 Days after Onset……………………………………………. 156
Figure 54 – CT Procedures Market Size [$M] by Scenario – 2020-2024…………………………………… 161
Figure 55 – A Chest Ultrasound Procedure…………….. 162
Figure 56 – CT and Ultrasound Scans from Two COVID-19 Patients…………………………………….. 163
Figure 57 – Ultrasound Procedures Market Size [$M] by Scenario – 2020-2024………………………. 168
Figure 58 – Peripheral GGOs with An Increased 18F-FDG Uptake In The Right Upper Lung And Left Lower Lung……………………………………. 169
Figure 59 – A PET-CT System……………………………… 171
Figure 60 – FDG-PET/CT Procedures & Wastewater Testing Market Size [$M] by Scenario – 2020-2024……………………………………… 175
Figure 61- A PACS Based Infrastructure Linked to RIS, Viewing Stations HIS and Teleradiology Optimizes the Workflow……………………. 177
Figure 62 – PACS Distributed Architecture……………… 178
Figure 63 – A Tablet Linked via Teleradiography to a COVID-19 Patient PACS Record……….. 181
Figure 64 – PACS & Teleradiology Market Size [$M] by Scenario – 2020-2024………………………. 183
Figure 65 – A PPE Set……………………………………….. 185
Figure 66 – Reusable ICU Gowns…………………………. 187
Figure 67 – PPE Gowns Market Size [$M] by Scenario – 2020-2024……………………………………… 192
Figure 68 -Medical Gloves………………………………….. 193
Figure 69 – Gloves Market Size [$M] by Scenario – 2020-2024…………………………………………….. 196
Figure 70 – Face Masks Compared………………………. 197
Figure 71 – When to Use a Respirator or a Surgical Mask……………………………………………………. 199
Figure 72 – N95 Respirator Layers……………………….. 200
Figure 73 – Face Masks Market Size [$M] by Scenario – 2020-2024……………………………………… 206
Figure 74 – Face Shields…………………………………….. 207
Figure 75 – Five Protective Shields Designs…………… 208
Figure 76 – Medical Face Shields Market Size [$M] by Scenario – 2020-2024………………………. 211
Figure 77 – Eye Protection Market Size [$M] by Scenario – 2020-2024……………………………………… 215
Figure 78 – PPE Sterilization: Systems & Consumables Market Size [$M] by Scenario – 2020-2024……………………………………………………. 217
Figure 79 – Hand & Surface Sanitizers Market Size [$M] by Scenario – 2020-2024………………….. 222
Figure 80 – Decontamination Market Size [$M] by Scenario – 2020-2024………………………. 230
Figure 81 – Other Personal Protection Gear Market Size [$M] by Scenario – 2020-2024……………. 232
Figure 82 – A COVID-19 CT Image……………………….. 242
Figure 83 – Signs of Pneumonia in a Chest X-ray……. 244
Figure 84 – COVID-19 AI, Big Data & Deep Learning Flow Diagram………………………………………… 245
Figure 85 – Receiver Operating Characteristic Curves of the Model………………………………………. 245
Figure 86 – Example of a COVID-19 Detection Neural Network………………………………………… 246
Figure 87 – AI, Big Data & Deep Learning Market Size [$M] by Scenario – 2020-2024……………. 251
Figure 88 – Homecare IT Flowchart………………………. 252
Figure 89 – Homecare IT Market Size [$M] by Scenario – 2020-2024……………………………………… 256
Figure 90 – Urban Pandemic Geo-Location System…. 259
Figure 91 – Countries Enacting Geo-Surveillance Services to Mitigate the COVID-19 Pandemic by March 2020…………………. 260
Figure 92 – Cellphone Displays the Private Kit APP…. 264
Figure 93 – Pandemic Geo-Location System without Cell Phones…………………………………………. 265
Figure 94 – The UK NHS COVID-19 Bluetooth App….. 266
Figure 95 – Hong Cong, S. Korea & Singapore who Used a COVID-19 Pandemic Geo-Surveillance Services Prove the Limited Spread of The COVID-19 Vs. Other Countries………….. 269
Figure 96 – Face Recognition as Used in China to Augment its Pandemic Geo-Location System………………………………………….. 270
Figure 97 – Geo-Surveillance Systems & Services Market Size [$M] by Scenario – 2020-2024…….. 271
Figure 98 – E-Health Market Size [$M] by Scenario – 2020-2024……………………………………… 276
Figure 99 – Blockchain Technologies Market Size [$M] by Scenario – 2020-2024………………………. 285
Figure 100 – Other ICT Market Size [$M] by Scenario – 2020-2024……………………………………… 292
Figure 101 – Non-Invasive Ventilator Demonstration… 294
Figure 102 – Mechanical Ventilator vs. Non-Invasive Ventilator………………………………………. 296
Figure 103 – Helmet-Based Non-Invasive Ventilator… 300
Figure 104 – Non-Invasive Ventilators Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution……………………. 302
Figure 105 – Noninvasive Ventilators Market Size [$M] by Scenario – 2020-2024………………………. 304
Figure 106 – A Mechanical Invasive Ventilator………… 305
Figure 107 – General Motors / Ventec, VOCSN Multi-function Ventilators Manufactured During April 2020………………………………………. 307
Figure 108 – A Mechanical Ventilator Function………… 309
Figure 109 – System Components Layout & Function. 311
Figure 110 – Invasive Mechanical Ventilators Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution……. 315
Figure 111 – Invasive Mechanical Ventilators Market Size [$M] by Scenario – 2020-2024……………. 317
Figure 112 – Next Generation Ventilators Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution……………………. 321
Figure 113 – Next Generation Ventilators Market Size [$M] by Scenario – 2020-2024……………. 323
Figure 114 – COVID-19 Homecare Elements………….. 325
Figure 115 – Homecare “ICU” Market: Barriers To Entry, Supplier Power, Buyer Power And Barriers To Substitution……………………………….. 330
Figure 116 – Homecare “ICU” (Equipment, Software, Services) Market Size [$M] by Scenario – 2020-2024……………………………………… 332
Figure 117 – A Smiths Group Portable Ventilator…….. 333
Figure 118 – An Invasive Portable Ventilator…………… 334
Figure 119 – Mobile Ventilators Market Size [$M] by Scenario – 2020-2024………………………. 338
Figure 120 – Italian Red Cross Surge Hospital Unit Installed During The Fiera Di San Rocco Pandemic………………………………………. 340
Figure 121 – 52 Bed Surge Hospital……………………… 340
Figure 122 – A Russian Tented Surge Hospital……….. 341
Figure 126 – Surge Capacity Hospitals Market Size [$M] by Scenario – 2020-2024………………….. 343
Figure 127 – Kidney Dialysis Market Size [$M] by Scenario – 2020-2024………………………. 349
Figure 128 – ECMO System………………………………… 350
Figure 129 – ECMO Machine Function………………….. 351
Figure 130 – Extracorporeal Oxygenation System Used for a COVID-19 Patient…………………….. 352
Figure 131 – Extracorporeal Membrane Oxygenation Procedures Market Size [$M] by Scenario – 2020-2024……………………………………… 357
Figure 132 – Typical COVID-19 ICU Equipment………. 358
Figure 133 – Other Intensive Care Modalities Market Size [$M] by Scenario – 2020-2024……………. 363
Figure 134 – Ford Manufactures Hospital Gowns with Airbag Material……………………………….. 364
Figure 135 – A Canadian (Canada Goose) PPE Gowns Production Line………………………………. 365
Figure 136 – Gowns Manufacturing Plants Market Size [$M] by Scenario – 2020-2024……………. 368
Figure 137 – Medical gloves coating machine…………. 370
Figure 138 – Medical PPE Gloves Manufacturing Machine………………………………………… 370
Figure 139 – Medical PPE Gloves Manufacturing Line 371
Figure 140 – Gloves Manufacturing Plants Market Size [$M] by Scenario – 2020-2024……………. 374
Figure 141 – A Production Line for the Manufacture Of Masks at a Factory in Shanghai…………. 376
Figure 142 – Automatic Face Mask Making Machine… 378
Figure 143 – N95 Face Mask……………………………….. 379
Figure 144 – A Garment Production Line Converted To Manufacture Face Masks…………………. 383
Figure 145 – An N95 Respirator Manufacturing Line… 384
Figure 146 – Automatic N95 Respirator Face Mask Forming Production Machine…………….. 385
Figure 147 – Face Masks Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…….. 388
Figure 148 – Face Shields Manufacturing Line………… 389
Figure 149 – President Trump Visits a New Face Shield Manufacturing Line………………………….. 390
Figure 150 – Face Shields Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…….. 392
Figure 151 – Test Kits Manufacturing…………………….. 393
Figure 152 – Test Kits Assembly Line……………………. 394
Figure 153 – Serologic Test Kits Manufacturing Plants Market Size [$M] by Scenario – 2020-2024……………………………………………………. 396
Figure 154 – Medical Grade Gown Made Of Melt-Blown Fabric…………………………………………… 398
Figure 155 – Melt-Blown PPE Fabric Manufacturing Machine………………………………………… 399
Figure 156 – Production Lines: Three Spun-Bonded Lines, One Melt-Blown Non-Woven Line and Three Lamination Lines, Producing Melt-Blown Material…………………………. 400
Figure 157 – Melt-Blown PPE Fabric Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…………………………………………….. 404
Figure 158 – Spun-Bond Manufacturing Method……… 405
Figure 159 – Spun-Bond Based Medical PPE…………. 406
Figure 160 – Spun Bond Manufacturing Machine…….. 407
Figure 161 – Spun-Bond PPE Fabric Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…………………………………………….. 409
Figure 31 – A self-collection PCR sample Kit………….. 410
Figure 162 – Self-collection PCR Test Kits Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…………………………………………….. 412
Figure 163 – Ventilators Production Line………………… 413
Figure 164 – ICU Ventilators per 100,000 People Over 65……………………………………………………. 414
Figure 165 – Ventilators Production Final Test Stage.. 415
Figure 166 – A German Ventilators Production Line…. 416
Figure 167 – Ventilators Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…….. 418
Figure 168 – PCR Reagents Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…….. 420
Figure 169 – PCR Systems Manufacturing Plants Market Size [$M] by Scenario – 2020-2024…….. 422
Figure 170 – Swabs Manufactures Machine……………. 423
Figure 171 – Swabs Manufacturing Plant……………….. 424
Figure 172 – Nose & Mouth Swabs Manufacturing Plants Market Size [$M] by Scenario – 2020-2024……………………………………………………. 427
Figure 173 – Medical Glass & Other Manufacturing Plants Market Size [$M] by Scenario – 2020-2024……………………………………………………. 429
Figure 174 – R&D Equipment & Consumables Market Size [$M] by Scenario – 2020-2024…….. 431
Figure 175 – Medical Glass and Other Products & Services Market Size [$M] by Scenario – 2020-2024……………………………………… 435
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 3
Figure 1 – Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario A – 2020-2024…… 15
Figure 2 – Hospitals and Surge Hospitals Market Shares by Region [%]: Scenario A – 2020-2024… 16
Figure 3 – Hospitals and Surge Hospitals Market Size by Region [$M]: Scenario B – 2020-2024…… 16
Figure 4 – Hospitals and Surge Hospitals Market Shares by Region [%]: Scenario B – 2020-2024… 17
Figure 5 – Hospitals and Surge Hospitals Markets Size [$M]: Scenarios A and B – 2020-2024…… 18
Figure 6 – Clinical Labs Market Size by Region [$M]: Scenario A – 2020-2024……………………… 20
Figure 7 – Clinical Labs Market Shares by Region [%]: Scenario A – 2020-2024……………………… 21
Figure 8 – Clinical Labs Market Size by Region [$M]: Scenario B – 2020-2024……………………… 21
Figure 9 – Clinical Labs Market Shares by Region [%]: Scenario B – 2020-2024……………………… 22
Figure 10 – Clinical Labs Market Size [$M]: Scenarios A and B – 2020-2024……………………………. 23
Figure 11 – Clinics Market Size by Region [$M]: Scenario A – 2020-2024………………………………….. 25
Figure 12 – Clinics Market Shares by Region [%]: Scenario A – 2020-2024……………………… 26
Figure 13 – Clinics Market Size by Region [$M]: Scenario B – 2020-2024………………………………….. 27
Figure 14 – Clinics Market Shares by Region [%]: Scenario B – 2020-2024……………………… 27
Figure 15 – Clinics Market Size [$M]: Scenarios A and B – 2020-2024………………………………………. 28
Figure 16 – Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario A – 2020-2024………………………………………………. 30
Figure 17 – Emergency Medical Services (EMS) Market Shares by Region [%]: Scenario A – 2020-2024………………………………………………. 31
Figure 18 – Emergency Medical Services (EMS) Market Size by Region [$M]: Scenario B – 2020-2024………………………………………………. 32
Figure 19 – Emergency Medical Services (EMS) Market Shares by Region [%]: Scenario B – 2020-2024………………………………………………. 32
Figure 20 – Emergency Medical Services Market Size [$M]: Scenarios A and B – 2020-2024…… 33
Figure 21 – Homecare & Nursing Homes Market Size by Region [$M]: Scenario A – 2020-2024…… 35
Figure 22 – Homecare & Nursing Homes Market Shares by Region [%]: Scenario A – 2020-2024… 36
Figure 23 – Homecare & Nursing Homes Market Size by Region [$M]: Scenario B – 2020-2024…… 37
Figure 24 – Homecare & Nursing Homes Market Shares by Region [%]: Scenario B – 2020-2024… 37
Figure 25 – Homecare & Nursing Homes Market Size [$M]: Scenarios A and B – 2020-2024…… 38
Figure 26 – Research Bodies Market Size by Region [$M]: Scenario A – 2020-2024……………………… 40
Figure 27 – Research Bodies Market Shares by Region [%]: Scenario A – 2020-2024……………….. 41
Figure 28 – Research Bodies Market Size by Region [$M]: Scenario B – 2020-2024……………………… 42
Figure 29 – Research Bodies Market Shares by Region [%]: Scenario B – 2020-2024……………….. 42
Figure 30 – Research Bodies Market Size [$M]: Scenarios A and B – 2020-2024…………………………. 43
Figure 31 – North America Vertical Markets’ Size [$M]: Scenario A – 2020-2024……………………… 45
Figure 32 – North America Vertical Markets’ Shares [%]: Scenario A – 2020-2024……………………… 46
Figure 33 – North America Vertical Markets’ Size [$M]: Scenario B – 2020-2024……………………… 47
Figure 34 – North America Vertical Markets’ Shares [%]: Scenario B – 2020-2024……………………… 47
Figure 35 – North America COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B.. 48
Figure 36 – North America Market Shares by Revenue Source [%]: Scenario A – 2020-2024…….. 50
Figure 37 – North America Market Shares by Revenue Source [%]: Scenario B – 2020-2024…….. 52
Figure 38 – Europe Vertical Markets’ Size [$M]: Scenario A – 2020-2024………………………………….. 54
Figure 39 – Europe Vertical Markets’ Shares [%]: Scenario A – 2020-2024……………………… 55
Figure 40 – Europe Vertical Markets’ Size [$M]: Scenario B – 2020-2024………………………………….. 56
Figure 41 – Europe Vertical Markets’ Shares [%]: Scenario B – 2020-2024……………………… 57
Figure 42 – Europe COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B…………….. 57
Figure 43 – Europe Market Shares by Revenue Source [%]: Scenario A – 2020-2024……………….. 59
Figure 44 – Europe Market Shares by Revenue Source [%]: Scenario B – 2020-2024……………….. 60
Figure 45 – Asia-Pacific Vertical Markets’ Size [$M]: Scenario A – 2020-2024……………………… 62
Figure 46 – Asia-Pacific Vertical Markets’ Shares [%]: Scenario A – 2020-2024……………………… 62
Figure 47 – Asia-Pacific Vertical Markets’ Size [$M]: Scenario B – 2020-2024……………………… 63
Figure 48 – Asia-Pacific Vertical Markets’ Shares [%]: Scenario B – 2020-2024……………………… 64
Figure 49 – Asia-Pacific COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B…………….. 64
Figure 50 – Asia-Pacific Market Shares by Revenue Source [%]: Scenario A – 2020-2024…….. 66
Figure 51 – Asia-Pacific Market Shares by Revenue Source [%]: Scenario B – 2020-2024…….. 68
Figure 52 – MEA & Latin America Vertical Markets’ Size [$M]: Scenario A – 2020-2024……………… 70
Figure 53 – MEA & Latin America Vertical Markets’ Shares [%]: Scenario A – 2020-2024…….. 71
Figure 54 – MEA & Latin America Vertical Markets’ Size [$M]: Scenario B – 2020-2024……………… 72
Figure 55 – MEA & Latin America Vertical Markets’ Shares [%]: Scenario B – 2020-2024…….. 72
Figure 56 – MEA & Latin America COVID-19 Pandemic Mitigation Market [$]: Scenarios A and B.. 73
Figure 57 – MEA & Latin America Market Shares by Revenue Source [%]: Scenario A – 2020-2024………………………………………………. 75
Figure 58 – MEA & Latin America Market Shares by Revenue Source [%]: Scenario B – 2020-2024………………………………………………. 77
Figure 59 – U.S. Confirmed Cases per Million Residents by State as of May 26, 2020……………….. 79
Figure 60 – USA Market Size [$M] by Scenario – 2020-2024………………………………………………. 80
Figure 61 – Canada Confirmed Cases per Million Residents by Province/Territory as of May 26, 2020…………………………………………. 82
Figure 62 – Canada Market Size [$M] by Scenario – 2020-2024………………………………………………. 83
Figure 63 – U.K. Confirmed Cases per Ten Thousand Residents as of May 26, 2020…………….. 85
Figure 64 – U.K. Market Size [$M] by Scenario – 2020-2024………………………………………………. 86
Figure 65 – Germany Confirmed Cases per 10,000 Inhabitants by District………………………… 88
Figure 66 – Germany Market Size [$M] by Scenario – 2020-2024………………………………………. 89
Figure 67 – France Deaths per Million Residents by Department……………………………………… 91
Figure 68 – France Market Size [$M] by Scenario – 2020-2024………………………………………………. 92
Figure 69 – Italy Confirmed Cases per Million Residents by Province (as of 25 May 2020)…………. 94
Figure 70 – Italy Market Size [$M] by Scenario – 2020-2024………………………………………………. 95
Figure 71 – Rest of Europe Market Size [$M] by Scenario – 2020-2024…………………………………….. 97
Figure 72 – Map of the Pandemic in India (as of 28 May 2020)……………………………………………… 99
Figure 73 – India Market Size [$M] by Scenario – 2020-2024…………………………………………….. 100
Figure 74 – Confirmed COVID-19 Cases in Mainland China per Million Inhabitants by Province as of 13 April 2020………………………………. 102
Figure 75 – China Market Size [$M] by Scenario – 2020-2024…………………………………………….. 103
Figure 76 – Confirmed Cases per Million Residents by Province or City in South Korea…………. 105
Figure 77 – South Korea Market Size [$M] by Scenario – 2020-2024……………………………………… 106
Figure 78 – Japan Confirmed Cases per Million Residents by Prefecture…………………… 108
Figure 79 – Japan Market Size [$M] by Scenario – 2020-2024…………………………………………….. 109
Figure 80 – Rest of Asia-Pacific Market Size [$M] by Scenario – 2020-2024………………………. 111
Figure 81 – ROW Market Size [$M] by Scenario – 2020-2024…………………………………………….. 113
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 4
This volume contains no figures
COVID-19 Pandemic Mitigation Products Market – 2020-2024 – Volume 5
Figure 1 – Hierarchy of Controls…………………………….. 41
Figure 2 – France National Stockpile of Face Masks….. 56
Figure 3 – Polymerase Chain Reaction Overview………. 73
Figure 4 – Industry Enabled Stabilization of Supply Chain……………………………………………………… 76
Figure 5 – Project Air Bridge………………………………….. 77
Figure 6 – Most Cases are never Counted……………….. 81
Figure 7 – The Difference between A PCR Test and an Antibody Test…………………………………… 90
Figure 8 – Capital Flows to Emerging Markets in Global Shocks………………………………………….. 100
Figure 9 – Depreciation Against the Dollar Since Jan. 1, 2020…………………………………………….. 101
US $
Euro €
GBP £